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ABSTRACT 
The regulation of cholesterol homeostatsis is of considerable interest because of 
the host of studies that show a clear positive relationship between plasma cholesterol 
levels and the risk of coronary heart disease. It has become apparent that plasma 
cholesterol levels are affected by a number of life style factors including the amount 
and type of fat in the diet. However, the mechanisms whereby dietary fat affects 
plasma cholesterol remain unclear. In this study we have investigated the effects of 
the levels and types of dietary fat on the cholesterol homeostasis. We used the FIB 
strain of hamster as a model as this strain has been shown to be sensitive to dietary fat 
induced atherosclerosis. We propose that this sensitivity reflects differences in the 
regulation of lipid metabolism between the FlB and the parent strain ofhamsters. 
Cholesterol homeostasis in the liver is tightly regulated by several sterol-sensitive 
regulatory proteins and receptors, including LDL receptor, HMG-CoA reductase, 
ACAT, CYP7, and SREBPs. It is postulated that the ER cholesterol is the cholesterol 
regulatory pool plays a major role in the regulation of these enzymes of the whole cell. 
We examined the effect of different dietary fats on the activity or expression of 
these proteins and observed that the activities of these enzymes are not directly 
regulated by the fats and cholesterol in the diet; instead, they appear more responsive 
to changes in the lipid environment of the microsome in the FlB hamster liver. Both 
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the HMG-CoA reductase and the ACAT activity are positively correlated with the level 
ofn-3 fatty acids in the microsome, andACAT activity also depend on the content of 
microsomal cholesterol. 
We suggested that the levels ofn-3 fatty acids and cholesterol in the diets may 
change the lipid composition microsomal membranes. This might alter membrane 
fluidity or the distribution of the key enzymes and regulatory proteins in the membrane 
of the ER. We suggest that the formation ofmicrodomains (rafts) may sequester 
much of the cholesterol into pools that are separate from the cholesterol regulatory 
pool in the ER. However, further studies on the lipid composition of these 
microdomains are needed for clarify our hypothesis. 
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Chapter 1. Introduction 
1.1 Lipoproteins and Coronary Heart Disease 
Despite extensive research for over five decades, coronary heart disease (CHD) 
remains a major cause of death and disability in Western countries. About 13 million 
Americans have CHD, 1.5 million have a myocardial infraction (MI) each year, and 
about 450,000 die of CHD each year (American Heart Association, 2004). For several 
decades there has been mounting evidence that the levels of cholesterol in the plasma can 
impact on the risk of developing CHD. 
CHD is caused by atherosclerosis, a process characterized by endothelial 
dysfunction and cholesterol deposition in macrophages and smooth muscle cells in the 
arterial wall as a result of elevated low density lipoproteins (LDL), increased 
lipoprotein( a), increased remnant lipoproteins, reduced LDL receptors and decreased 
high density lipoproteins (HDL). During this process, proliferation, inflammation and 
calcification of smooth muscle and thrombosis can occur resulting in narrowing of the 
arteries leading to myocardial infarction or death of heart muscle (Schaefer, 2002). 
Hypercholesterolemia is critical in the development of atherosclerosis. An 
investigation of over 356,000 healthy males for 10 years by the National Heart, Lung, 
and Blood Institute (NHLBI) showed a strong correlation between the rate of CHD death 
and the plasma total cholesterol (TC) concentration (Figure 1.1) (1988;Stamler eta/., 
1986). These data suggest that there is a direct relationship between the serum TC and 
the rate of death from CHD.It is clear from these data that death due to CHD is very 
uncommon in individuals with a serum TC < 3.6 mM (140mg/dl) (Dietschy, 1998). 
Major risk factors associated with atherosclerosis are elevated levels of plasma 
cholesterol, decreased levels ofHDL, elevated levels of very low density lipoproteins 
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Figure 1.1. Mortality rates from coronary heart disease (CHD) as a function of 
serum total cholesterol (TC) concentrations. 
These curves were constructed after recalculating data from two sources and show 
the number of deaths per 1000 patients per 10 years. The dashed curve comes from an 
analysis of nearly 356,000 men (1988;Stamler et al., 1986). The four data points in the 
lower solid curve were recalculated from a more recent study in urban Chinese 
populations (Chen et al., 1991). 
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(VLDL) plus LDL, elevated levels oftriacylglycerols, and hypertension. 
Since lipids, including cholesterol, are insoluble in the blood, they are transported in 
the plasma in particles known as lipoproteins. Among the lipoproteins, the LDL 
represents the major cholesterol carrying lipoprotein in human plasma and its uptake by 
the cells is carefully regulated (Havel, 1997). However, when LDL becomes oxidized in 
the arterial wall, a separate receptor pathway leads to its uncontrolled uptake by 
macrophages and the formation of foam cells (Krieger and Herz, 1994). In contrast, 
HDL appears to protect the arterial wall from the development of atherosclerosis by 
removing cholesterol from the intima through its role in the reverse cholesterol transport 
pathway (Fielding and Fielding, 1995) and by preventing the oxidation ofLDL. 
1.2 Dietary Fats and Plasma Lipoproteins 
Over the past 25 years, epidemiological studies have shown that the level of dietary 
fat is positively correlated with the serum TC value and mortality from CHD (Epstein, 
1989). Early studies also established that isocaloric substitution of unsaturated fats 
derived mostly from vegetable oil, for saturated fats from animal sources decreased the 
serum TC concentration in humans (Aharens, Jr., 1957; Keys eta!., 1957; Kinsell eta!., 
1952). Moreover, early studies by Bang and Dyerberg demonstrated that diets rich in 
omega-3 polyunsaturated fatty acids (n-3 PUFA) appear to be especially effective at 
reducing atherogenesis (Bang eta!., 1971). 
Initial studies suggested that the lipoprotein fraction most affected by the levels and 
types of dietary fats was the LDL (Aharens, Jr., 1957; Keys eta!., 1957; Kinsell eta!., 
1952). However, later it was found that the levels of both atherogenic LDL-cholesterol 
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(LDL-C) and the anti-atherogenic HDL- cholesterol (HDL-C) are affected by dietary 
lipids, but the changes in HDL were modest (Lewis, 1990). Many controlled feeding 
studies on the effects of different dietary fatty acids on plasma cholesterol have been 
summarized in several meta-analyses (Hegsted et al., 1965; Hegsted eta!., 1993; Hu and 
Willett, 2002; Keys and Parlin, 1966; Mensink and Katan, 1992;Yu et al., 1995). They 
reported that saturated fatty acids increased, and polyunsaturated fatty acids decreased 
TC and LDL-C. When saturated, monounsaturated, and polyunsaturated fatty acids 
replaced carbohydrates in the diet, they all increased HDL-C and saturated fatty acids had 
a slightly greater effect than the other two. Since the substitution of saturated fats with 
carbohydrates of the diet decreased both LDL-C and HDL-C proportionally, it had little 
effect on the LDL-HDL ratio. Thus substitution would be expected to have less benefit 
on CHD risk. The monounsaturated and polyunsaturated fatty acids, on the other hand, 
markedly decreased the LDL-HDL ratio and could decrease CHD risk. 
1.3 Liver's Role on The Regulation of Serum Cholesterol at Cellular Level 
The plasma LDL-C concentration is determined by the balance between the rate of 
production and clearance of this lipoprotein from circulation (Brown et al., 1981 ). The 
VLDL is synthesized in the liver and serves to transfer triacylglycerol from the liver to 
peripheral tissue for storage or utilization as a metabolic fuel. As the VLDL 
triacylglycerol is hydrolyzed, the size ofVLDL is reduced. Some of the VLDL 
remnants, now called Intermediate Density Lipoproteins (IDL), are taken up directly by 
the LDL-receptor (LDL-r) back into the liver. The rest is converted to LDL and 
subsequently cleared by the liver though the same mechanism (Dietschy et al., 1993). 
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Because the liver may play an important role in changing the plasma LDL-C levels, it is 
suggested that variation of dietary fats may affect LDL-C levels through effects on the 
liver. However, it is not clear if this involves effects on LDL clearance, cholesterol 
production, or both. 
Cholesterol homeostasis in the liver is regulated by several sterol-sensitive 
regulatory proteins and receptors, which are primarily associated with the endoplasmic 
reticulum (ER) and, in some cases, they are associated with plasma or outer nuclear 
membrane. These include a) cholesterol uptake via LDL and other protein receptors 
(Borchardt and Davis, 1987;Dietschy, 1998); b) HMG-CoA reductase (HMG-R), the 
rate-limiting step in the cholesterol biosynthesis pathway (Orci et al., 1984); c) CYP7Al 
and CYP27, the initial enzymes in the classic and alternative pathways ofbile acid 
synthesis, respectively (Russell and Setchell, 1992); d) acyl-coenzyme A:cholesterol 
acyltransferase (ACAT) (Chang eta/., 1997;Lange eta/., 1993) and neutral cholesterol 
ester hydrolase (CEH), the enzymes that regulate the pool sizes of free and esterifed 
cholesterol compartments in the liver; e) the precursor forms of regulators of 
transcription (SREPBs) (Horton et a/., 2002), and f) pro teases that modulate some of 
these factors (SCAP, SIP, S2P) (Edwards eta/., 2000). All of these proteins respond to 
changes in cell cholesterol. In particular, a regulated pool of cholesterol in the ER might 
serve as a control element in cholesterol homeostasis (Lange eta/., 1993). 
The existence of a putative ER cholesterol regulatory pool involved in determining 
the activity of key enzymes just mentioned in cholesterol homeostasis has been 
postulated for many years (Edwards and Ericsson, 1999). In human fibroblasts, 85% of 
free cholesterol is in the plasma membrane (Lange et a/., 1989) and perhaps 10% is in the 
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(Lange, 1991). One measure of the ER cholesterol suggests that it contains ~0.5% ofthe 
total unesterified cholesterol in the cell (Lange and Steck, 1997). The level of the ER 
pool is set by a brisk circulation of cholesterol to and from plasma membrane and a small 
change in plasma membrane cholesterol near the physiologic set point induces large 
responses in ER cholesterol (Lange et al., 1999). The ER sterol-sensitive proteins then 
induce cholesterol esterification, decrease its biosynthesis, and suppress transcription 
factor precursors that activate genes promoting cholesterol accretion. These responses 
complete a feedback mechanism that maintains the plasma membrane cholesterol pool at 
the physiological level (Lange et al., 2004). 
1.4 The FlB Hamster as a CHD Model 
A major challenge in our efforts to completely understand the molecular basis for 
the initiation and development of CHD is the insidious nature of the disease. A number 
of animal models have been used including rodents, rabbits, miniature swine and 
hamsters. Some of these have been more useful than others. The hamster has proved to 
be a good model to study lipoprotein metabolism since the concentration of serum LDL-
cholesterol responds to changes in dietary lipids in a similar manner to that seen in 
human serum (Spady and Dietschy, 1985; Spady and Dietschy, 1988). 
These changes in hamster include similarities to the human: a) cholesterol and bile 
acid metabolism (Spady and Dietschy, 1983); b) non-high density lipoprotein (LDL) 
cholesterol and triglyceride response to an atherogenic diet (Spady and Dietschy, 1988); 
c) development of atherosclerotic lesions similar to those found in early stages of disease 
(Nistor et al., 1987); d) exclusive hepatic production of apolipoprotein ( apo) B-1 00 
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(Arbeeny et al., I992). Thus, the hamster has been used extensively as a model for 
investigation of the effects of dietary fats on cholesterol regulation and atherogenesis 
(Parker eta/. I995; Kahion eta/., 1996; Nicolosi eta/. 1998; Margiapane eta/., I999). 
The normal Golden Syrian hamster, however, is somewhat resistant to dietary 
cholesterol-induced atherosclerosis (Nistor et al., I987; Margiapane et al., I999. In 
contrast, a hybrid strain (FIB hamster), has been shown to develop atherosclerotic lesions 
fairly quickly when fed with low levels of cholesterol (Kowala et al., I99I ). Moreover, 
the FIB hamster develops lesions that are histologically similar to those in humans 
(McAteer et al., 2003). This has made the FIB hamster an excellent model for study of 
the effects of dietary fats on the molecular mechanisms involved in atherogenesis. 
1.5 Previous Study and Present Focus 
This work is a follow up from a previous study in our laboratory carried out by 
P. de Silva. The previous study was designed to examine the effects of dietary lipids 
(PUFA and cholesterol) on the regulation of lipoprotein metabolism in the FIB hamster. 
The animals were fed with 8 different diets rich in n-3 (n-3/n-6=10/1; fish oil diet) or n-6 
fatty acids (n-3/n-6=I/IO; mix diet) at low (5%, w/w) or high (20%, w/w) fat levels with 
O.I or 0.25% (w/w) cholesterol. 
Those results were the first to demonstrate that fish oil caused hyperlipidemia in 
FIB hamsters. Other key findings from that study were: 
a) serum total cholesterol, VLDL- and LDL-cholesterol concentration 
were significantly higher with lower HDL-cholesterol in hamsters fed 
with fish oil diets compared to animals fed with mix diets, 
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b) higher amount of fats in the diets increased plasma lipids in all groups 
but fish oil groups showed higher serum lipid levels especially in high 
fat groups, 
c) the hepatic cholesterol content was not significantly different between 
groups, 
d) the LDL-receptor mRNA was lower in the animals fed with fish oil 
diets, and may contradict the well known hypolipidemic and 
hyperlipidemic effects of dietary n-3 fatty acids and cholesterol; 
respectively. 
In the present study, our goal is to explore cholesterol metabolism in the FIB 
hamster caused by dietary PUF A and cholesterol at the hepatic cellular level. We looked 
at the expression levels of several microsomal proteins, including HMG-CoA reductase, 
ACATAl, CYP7, and transcription factors (SREBPs), involved in the cellular cholesterol 
homeostasis in hamster liver. 
1.6 Feedback Regulation ofHMG-CoA Reductase Activity 
Feedback regulation of cholesterol biosynthesis was first recognized nearly 50 years 
ago by Gould and his colleagues (Gould et al., 1953). It takes place primarily in the liver 
and is exerted mainly on HMG-CoA reductase and plays a critical role in overall 
cholesterol homeostasis. Many studies have focused on transcription, translation, protein 
turnover and regulation of catalytic efficiency by phosphorylation/dephosphorylation 
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regulated at multiple levels (Brown and Goldstein, 1980). However, recent studies on rats 
showed that a cholesterol-supplemented diet significantly decreased both HMG-CoA 
reductase activity and protein levels (Chambers and Ness, 1998;Ness et al., 1994), and 
thus suggested that feedback regulation of hepatic HMG-CoA reductase by dietary 
cholesterol occurs mainly by decreasing the amount ofHMG-CoA protein rather than 
inactivating the enzyme by phosphorylation. 
1.6.2 Different HMG-CoA Reductase Activity Among Various Species 
Feeding rats diets containing 2% cholesterol markedly reduced hepatic HMG-CoA 
reductase activity but had little effect on HMG-CoA reductase mRNA levels (Ness et al., 
1991). Rats fed with cholesterol or the bile salt, cholate, showed a marked reduction in 
the rate of hepatic cholesterol synthesis (by approximately 75% with bile salt, 90% with 
cholesterol), but only moderate reductions were observed in HMG-CoA reductase mRNA 
level (40% reduction) (Spady and Cuthbert, 1992). This suggested that dietary 
cholesterol feedback in rat liver is exerted primarily at the posttranscriptionallevel. 
In contrast to the studies in rats, experiments on cholesterol feedback regulation of 
hepatic HMG-CoA reductase in both hamsters and mice have revealed an apparent 
transcriptional regulation. Feeding mice with cholesterol reduced HMG-CoA reductase 
mRNA level to only 25% of the control in the liver (Rudling, 1992). Similar results are 
also seen in a hamster model with a decrease of 85% in mRNA level when the diet was 
supplemented with cholesterol (Gil et al., 1986). These results indicated that dietary 
cholesterol exerted feedback regulation primarily at transcriptional level in mice and 
hamsters. Thus the different animal experiments indicate that transcriptional regulation 
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as a mechanism for feedback regulation of HMG-CoA reductase may be more important 
in mice and hamsters which are cholesterol-sensitive animals; but it plays a minor role in 
rats that are relatively dietary resistant to cholesterol. 
1.6.3 Regulatory Mechanisms of HMG-CoA Reductase 
Recently the transcriptional regulation of HMG-CoA reductase has been shown to 
involve the binding of sterol regulatory element binding proteins (SREBPs) to sterol 
regulatory elements (SREs) within the promoter region of the HMG-CoA reductase gene 
(Brown and Goldstein, 1997;Vallett et al., 1996). This concept of transcriptional control 
is supported by the observation that treatment with Cholestyramine (a bile acid 
sequestrant) and Mevinolin (a HMG-CoA reductase inhibitor) increased the amount of 
HMG-CoA reductase protein in rat liver by elevating the amount of its mRNA. In 
addition, feeding cholesterol to rats treated with these agents lowered the amount of 
hepatic HMG-CoA reductase protein by decreasing the level of its mRNA (Liscum et al., 
1983). Similar results have been observed using cultured tumor cells (Brown and 
Goldstein, 1997). The role of SREBPs and their regulation will be discussed later. 
1.6.4 Dietary Polyunsaturated Fatty Acids Inhibit HMG-CoA Reductase Activity 
The effects of polyunsaturated fatty acids (PUF A) on HMG-CoA reductase have 
been intensively studied in rats since the 1980's. An early study showed that rat hepatic 
HMG-CoA reductase activity was inversely correlated with levels of dietary 
polyunsaturated fatty acids (Ide et al., 1978). Later studies showed that diets 
supplemented with both n-3 PUF A (fish oil) and n-6 PUF A (safflower seed oil) lower 
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HMG-CoA reductase activity, but that n-3 fatty acids were much more effective than n-
6 fatty acids at reducing the activity (Choi et al., 1989;Mitropoulos et al., 1980). Similar 
results were also seen when rats were intravenously infused for two weeks with a fat 
emulsion containing 20% oftriacylglycerol in which either n-6 or n-3 fatty acids 
predominated (al Shurbaji et al., 1991). 
Similar studies have also been done with rabbits, that have a much lower hepatic 
HMG-CoA reductase activity than rats (Shapiro and Rodwell, 1971). The hepatic HMG-
CoA reductase activity was further reduced when rabbits were fed for two days with a 
1% cholesterol and 5% com oil mix diet compared to the cholesterol diet without com 
oil. This suggests that rabbit HMG-CoA reductase has kinetic properties similar to the 
rat HMG-CoA reductase (Stange et al., 1981). Another study showed that dietary n-3 
fatty acids decreased HMG-CoA reductase activity by 76% compared to normal rabbit 
chow, and additional cholesterol (1 %) further reduced the activity to 10% of the control 
(Field et al., 1987). The effects of dietary unsaturated fatty acids on hepatic HMG-CoA 
reductase found in mice are similar to those seen in rats and rabbits. Compared to n -6 
PUF A, supplementation for one week with dietary n-3 fatty acids further reduced the 
specific activity of the HMG-CoA reductase. These differences were due, at least in 
part, to differences in the amount of HMG-CoA reductase protein (El Sohemy and 
Archer, 1999). These results have been confirmed in a recent long-term feeding study 
(Du et al., 2003 ). 
A long-term feeding experiment on mice indicated that the hypocholesterolemic 
activity of dietary polyunsaturated fatty acids is exerted by n-3 fatty acid-rich oils by 
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suppressing hepatic HMG-CoA reductase activity compared with animal fats and high-
linoleic (n-6) oil (Duet al., 2003). 
In conclusion, dietary n-3 fatty acids were a major factor in the dietary unsaturated 
fatty acid mediated regulation of cholesterol biosynthesis and they exerted their effect by 
suppressing hepatic HMG-CoA reductase activity. Additional dietary cholesterol further 
reduced the HMG-CoA reductase activity. 
1.7 Cholesterol 7 alpha-hydroxylase (CYP7Al hydroxylase) 
Bile acid synthesis from cholesterol is a major pathway for elimination of cholesterol 
from the body, occurring either via the classic (also called "natural") or alternative (also 
called "acid") bile acid synthesis pathways (Vlahcevic et al., 1999). Bile acids represent 
the terminal end products of cholesterol catabolism, and their synthesis takes place 
exclusively in the liver (Vlahcevic et al., 1999). The pathway of bile acid synthesis in the 
enterohepatic circulation is controlled by a microsomal enzyme known as cholesterol-7a-
hydroxylase (CYP7 Al ). The activity of CYP7 AI is regulated by a variety of nutritional 
and hormonal factors involving both feedback and feedforward mechanisms. The 
regulatory control appears to be exerted mainly at the level of gene transcription, because 
CYP7Al activity is highly correlated with its mRNA level. 
1.7.1 Regulation ofCYP7Al Activity 
Many experiments on rodents showed that CYP7Al gene expression is suppressed 
by bile acids and stimulated by cholesterol. The stimulation ofCYP7Al gene expression 
by cholesterol is mediated through liver X receptor (LXRa), an oxysterol-activated 
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nuclear receptor that binds to the CYP7 A1 gene promoter as a heterodimer with another 
nuclear receptor known as retinoid X receptor (RXR) (Lehmann eta/., 1997;Peet eta/., 
1998). Different species vary widely in their response to dietary cholesterol. The rat 
responds to cholesterol feeding with induction ofCYP7A1 and bile acid synthesis, is 
relatively resistant to development of hypercholesterolemia. In contrast, increased 
dietary cholesterol fails to induce CYP7 A 1 in rabbits (Xu et a/., 1996), green monkey 
(Rudel eta/., 1994), and hamsters (Horton eta/., 1995). In these species, excess 
cholesterol results in the development of hypercholesterolemia and atherosclerosis. The 
ability of most humans to respond to excess dietary cholesterol is probably more like the 
hamster. In humans, the active LXR site is absent in the CYP7 A1 promoter. This region 
of the human CYP7 A 1 promoter contains a hepatocyte nuclear factor-1 (HNF 1) binding 
site (Chen eta/., 1999;Molowa eta/., 1992). Differences in LXRa activation sites in the 
CYP7 A 1 promoter may explain the species-specific difference in response to dietary 
cholesterol. 
The inhibition ofCYP7A1 gene expression by bile acids is mediated through an 
indirect mechanism. Previous studies identified the nuclear receptor FXRa as the major 
hepatic bile acid sensor that governs bile acid synthesis and transport (Clifford eta/., 
1976;Mortara eta/., 1976;Wang eta/., 1999). Bile acids are potent ligands ofFXRa, 
which induces the expression of SHP (small heterodimer partner). Elevated levels of 
SHP in tum lead to transcriptional repression of the CYP7A1 gene, by inhibiting the 
activity of nuclear receptor LRH-1 on the CYP7A1 promoter (Goodwin eta/., 2000;Lu et 
a/., 2000). SHP is an atypical nuclear receptor lacking a DNA-binding domain (Seol et 
a/., 1996). It contains anN-terminal receptor dimerization domain, which mediates its 
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recruitment to promoter via interaction with various nuclear receptors. SHP is expressed 
at low levels in the liver (Goodwin et al., 2000;Lu et al., 2000). 
1.7.2 Effects ofPUFA on Bile Acid Synthesis 
Recently, the liver X receptors (LXRa and LXR~) were identified as targets for fatty 
acid regulation (Ou et al., 2001 ). Unsaturated fatty acids antagonize oxysterol activation 
by LXRa in Hek 293 and hepatoma cell lines by interfering with oxysterol binding. 
Although such studies suggest that changes in hepatic PUF A levels might affect bile acid 
synthesis in vivo, feeding studies with mice have yet to support this view. Interestingly, 
hepatic 7o:,-hydroxylase (CYP7Al) activity and its mRNA levels are not suppressed in 
mice fed diets supplemented with unsaturated fatty acids (Cheema et al., 1997;Cheema 
and Agellon, 1999). 
1.8 Acyl-CoA:cholesterol acyltransferase (ACAT) 
Acyl-CoA:cholesterol acyltransferase (ACAT) is an integral enzyme present in the 
rough ER that catalyzes the esterification of cholesterol from free cholesterol and fatty 
acyl coenzyme A. This mechanism is apparently in response to an increased ER 
cholesterol pool and believed to be activated as a means to remove excess cholesterol, 
and the esters are deposited in the cytosolic lipid droplets (Simons and Ikonen, 2000). 
Under pathological conditions, cholesterol esters produced by the ACAT reaction 
accumulate as lipid droplets in macrophages and eventually cause foam cell formation in 
the early stage in the formation of atherosclerotic plaques (Chang et al., 2006). Due to 
the technical difficulties of directly tracing the cholesterol movement in the cell, the level 
16 
of cholesterol esterification has become the standard method for monitoring the 
cholesterol transport to the ER and is assumed to reflect the ER cholesterol pool (Debry 
et al., 1997; Lange and Steck, 1997). 
Two isoforms of ACAT (ACAT-1, ACAT-2) were found in several species 
including mice (Cases et al., 1998), humans (Oelkers et al., 1998) and other primates. 
ACAT -1 is ubiquitously expressed with its active site oriented toward the cytosol, and 
mainly served to protect cell membranes from the toxicity of excess free cholesterol. 
ACAT-2, however, is expressed primarily in the liver and intestine with the active site 
faced towards the lumen of the ER, suggesting that ACAT -2 may play an important role 
in the synthesis and secretion ofhepatic lipoproteins, and the cholesterol absorption from 
small intestine (Carr et al., 1995). While the structure and general function of ACAT are 
well defined, less is known of the factors that regulate ACAT activity. 
1.8.1 Regulation of ACATAl Activity 
ACATA1 appears to be regulated mainly by post-translational mechanisms (Chang 
et al., 1997). Cholesterol esterification is elevated in cholesterol-loaded cells without 
changes in ACATAl mRNA (Matsuda et al., 1996; Rea et al., 1996; Wang et al., 1996) 
or protein expression levels (Chang et al., 1994; Wang eta!., 1996; Yu et al., 1999). The 
in vitro studies using purified ACATAl support the hypothesis that ACATAl is 
allosterically activated by binding to cholesterol or oxysterol (Chang et al., 1998). 
ACAT may also be regulated at the transcriptional level. The ACATAl mRNA level 
increased after feeding a cholesterol-rich diet to mice (Uelmen et al., 1995) or rabbit 
(Pape et al., 1995). The significant increase ofmRNA was also found in human 
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macrophages during the differentiation ofmonocytes into macrophages (Wang et al., 
1996). 
1.8.2 Effect ofPUFA on ACATAl Activity 
Early in vivo studies have shown that, compared with saturated fat diets, diets high 
in unsaturated fatty acids increase liver ACAT activity (Field et al., 1987;Spector et al., 
1980). In vitro studies suggested that unsaturated fatty acids also directly induce cellular 
ACAT activity (Rumsey et al., 1995). However recent in vitro studies showed that 
different unsaturated fatty acids induce ACATA1 mRNA levels in cell specific (HepG2) 
manner; this does not appear to correlate with the ACAT activity (Seo et al., 2001). 
Interestingly hepatic ACAT activity was lower in hamsters fed dietary fats containing 
acyl groups with 18:1c and 18:2c fatty acids compared with those fed diets containing 
16:0 (Bhatty eta/., 2001). 
1.9 Sterol Regulatory Element Binding Proteins (SREBPs) 
With the recent discovery of the sterol regulatory elements (SREs) in the promoter 
region of genes, a family of transcription factors, called sterol regulatory element binding 
proteins (SREBPs ), has been suggested to regulate more than 30 genes involved in the 
cellular homeostasis of cholesterol and fatty acids (Brown and Goldstein, 1997 ;Edwards 
eta/., 2000;Horton and Shimomura, 1999;Sakakura et al., 2001). In cholesterol 
metabolism, SREBPs activate target genes encoding HMG-CoA synthase (Smith et al., 
1988), HMG-CoA reductase (Vallett eta/., 1996), farnesyl diphosphate synthase 
(Ericsson et al., 1996) and squalene synthase (Guan et al., 1997), and LDL-receptor 
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which mediates the cellular uptake of cholesterol from plasma (Brown and Goldstein, 
1986). 
SREBPs belong to the basic helix-loop-helix-leucine zipper (bHLH-Zip) family of 
transcription factors. They are first synthesized as inactive precursors, bound to rough 
endoplasmic reticulum (ER), containing approximately 1150 amino acids organized into 
three domains: (i) an NH2-terminal of about 500 amino acids containing bHLH-Zip 
region for DNA binding; (ii) a middle hydrophobic region of about 80 amino acids 
containing two hydrophobic transmembrane-spanning segments interrupted by a short 
loop of about 30 amino acids that projects into the lumen ofER; and (iii) the COOH-
terminal regulatory domain of about 590 amino acids. Both NH2-and COOH- terminals 
project into the cytosol of cells (Brown and Goldstein, 1997). 
To date, three SREBP isoforms have been identified in mammalian cells. SREBP-la 
and SREBP-1 c are derived from a single gene by use of alternative promoters and 
splicing, resulting in different forms of exon-1. The SREBP-2 is encoded by a separate 
gene. In growing cultured cells, the SREBP-la and SREBP-2 are predominant; but in 
most animal tissues, the SREBP-lc and SREBP-2 are predominant. SREBP-1 has been 
shown to preferentially activate genes required for fatty acid synthesis; in contrast, 
SREBP-2 preferentially activates genes involved in cholesterol homeostasis (Shimomura 
eta!., 1997). 
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1.9.1 Regulation of SREBP by Cholesterol 
In order to enter the nucleus and activate target genes, theN-terminal bHLH-Zip 
domain, often referred to as the nuclear form of SREBPs (nSREBPs) must be released 
from the ER membrane by a two-step proteolysis. Initially SREBP precursor (pSREBP) 
and SCAP are both inserted into the membrane of roughER with a protein-protein 
interaction which is required for SCAP to control the processing of SREBP (Sakai et al., 
1997; Sakai et al., 1998). When cells need cholesterol, SCAP senses this need through 
its membranous sterol-sensing domain and escorts the SREBP from the ER to the Golgi 
apparatus where site-1 (SIP) and site-2 (S2P) proteases await. In the Golgi, a membrane-
bound serine protease, SIP, cleaves the SREBP in the luminal loop dividing the precursor 
in half. Then S2P, a membrane-bound zinc metalloproteinase, cleaves SREBP in the first 
transmembrane domain releasing theN-terminal domain, nSREBP, from the ER 
membrane. The nSREBP then enters the nucleus and binds to SRE in the promoter 
regions of target genes, including HMG-CoA reductase and LRL-receptor, for 
transcriptional activation. When cholesterol is abundant in the cells, the SREBP/SCAP 
complex is retained in the rough ER and no cleavage occurs. Therefore the nSREBP can 
not enter the nucleus to activate SER-related genes. The mechanism by which SCAP 
senses the cellular sterol level and escorts the SREBP/SCAP complex from ER to Golgi 
is still unknown (Horton et al., 2002). 
Recently other integral-membrane proteins, insulin-induced gene-1 (Insig-1) and 
Insig-2 have been found in the ER, which may bind to the SCAP and cause the ER 
retention ofSCAP/SREBP complex (Yabe et al., 2002; Yang et al., 2002). In Drosophila 
cells, sterols block transport of the mammalian SCAP/SREBP-2 complex only when 
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Insig-1 or Insig-2 is co-expressed (Dobrosotskaya et al., 2003). The addition of 
cholesterol to the ER membranes causes a conformational change in the cytoplasmic loop 
of SCAP, and the amount of cholesterol required for this conformational change is 
decreased in the presence of Insig proteins, therefore facilitating the retention of 
SCAP/SREBP complex in the ER (Adams et al., 2003). In addition, Insig-1 has been 
shown to enhance the degradation ofHMG-CoA reductase by binding to its sterol-
sensitive domain when cholesterol levels are high (Sever et al., 2003), suggesting a dual 
role for Insigs in the SCAP/SREBP pathway and the regulation of cholesterol 
metabolism. 
1.9.2 Effects of Unsaturated Fatty Acids on SREBPs 
Dietary polyunsaturated fatty acids have been well established as negative regulators 
of hepatic lipogenesis. Thus, several laboratories have investigated whether the 
unsaturated fatty acids have feedback effects of SREBPs. Briefly, these reports all 
indicated that PUF A suppress the expression of SREBPs, but the mechanism is different 
in cell culture and in animals. Xu et al. (Xu et al., 1999) found that dietary (n-3) and (n-6) 
PUF A, but not saturated or (n-9) unsaturated fatty acids unequally reduce the hepatic 
abundance of SREBP-1 mRNA and both the precursor and nuclear form of SREBP-1. 
This inhibition is paralleled by significant reduction in the transcription of hepatic fatty 
acid synthesis. A later study showed that PUF A decrease the hepatic SREBP-1 by 
accelerating the rate ofmRNA decay (Xu et al., 2001). Kim et al. (Kim et al., 1999) 
found that long-term feeding of mice with a fish oil diet enriched in n-3 PUPA decreased 
nuclear form ofboth SREBP-1 and -2 in the liver. The mRNA ofSREBP-1 was reduced 
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significantly, but SREBP-2 was only partially reduced. Recently, Hannah et al. (Hannah 
et al., 2001) suggested that not only the unsaturated fatty acids reduce the nSREBP-1 in 
HEK-293 cells by suppressing the proteolytic release ofnSREBP-1, but they found that 
16:1(n-9) and 18:1(n-9) were as effective as n-3 and n-6 PUFA at suppressing the 
processing of SREBP-1. Therefore fatty acids may exert their effects on SREBPs 
differently in animals and cell lines. 
1.10 Hypothesis and objectives 
Based on the current understanding of the regulation of cholesterol metabolism by 
dietary fatty acids and cholesterol we proposed that the hyperlipidemic effects of dietary 
fat observed in the FIB hamster reflects abnormalities in the regulatory mechanisms in 
the liver of this atherosclerosis prone animal model, including the SREBP mediated 
control of cholesterol biosynthesis. 
The objective of this study was to investigate the biochemical regulation of 
cholesterol metabolism in the liver ofF1B hamsters caused by different dietary PUF A 
and cholesterol. We looked at the expression of several microsomal enzymes that play 
key roles in cholesterol metabolism in liver including, HMG-CoA reductase, CYP7, 
ACAT, a corresponding transcription factor, SREBP-2,. We also examined the lipid 
composition in the microsomal membrane in the animals fed different diets. 
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Chapter 2. Methodology 
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2.1 Animals and Diets. 
The F1B hamsters (male, 7 weeks of age) were purchased from Bio Breeder Inc. 
(Water Town, MA) and fed a chow diet for a one week equilibration period. This was 
reported to be sufficient time to allow the animals to recover from shipping and 
acclimatize to new housing (Landi et al., 1982; Dymsza et al., 1963). This also allowed 
the animals to become adjusted to the 12h light/12h dark conditions as the plasma lipid 
response in the FIB hamster has been reported to be sensitive to both photoperiod and 
caging (Smith et al., 2001 ). The animals were separated into 8 groups and fed with one of 
the experimental diets. The contents of the diet included fat free semi-purified diet (ICN 
Biomedical INC., Cleveland, OH, catalog# 960241) and either fish oil (menhaden oil) or 
a mixture of lard and safflower oil in 1.5:1 ratio (mix diet). Lard and safflower oils were 
obtained from a local supermarket. The components ofthe diets are shown in Table 2.1. 
Diets were prepared with two levels of fat, 5% (w/w) (low fat) and 20% (w/w) (high fat). 
Due to the presence of small amounts of cholesterol in the fish oil, a similar amount of 
cholesterol (98% pure, Sigma-Aldrich, St. Louis, MO) was added to the MIX diets to 
make the cholesterol levels similar to the fish oil diets. In order to elevate the cholesterol 
level to a concentration of0.25% (w/w) in both fish oil and MIX diets, additional 
cholesterol was added to both diets. The fatty acid composition of the diets is given in 
Table 2.2. 
The animals were housed in a controlled environment with a 12hr (lights on from 
07.00 to 19.00 hours) light/dark cycle and were given free access to water and diets. The 
temperature was maintained at 21° C, with humidity kept at 3 5±5 %. After two weeks on 
the specific diets, some of the animals started to lose weight, thus for this pilot project we 
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Table 2.1 Components of the Experimental Diets at Low (5%) and High (20%) Fat 
Level. (%, w/w) 
LowFatDiee 
Fish Oil Diet Mix Diet< 
Componentsd Low High Low 
Chol Chol Chol 
Sucrose 50 50 50 
Casein 20 20 20 
Maize starch 14.6 14.6 14.6 
DL-Methionine 0.03 0.03 0.03 
Mineral mix• 4 4 4 
Vitamin mix• 1.1 1.1 1.1 
Fiber' 5 5 5 
Fat 5 5 5 
Cholesterol 0.1 0.25 0.1 
chol, cholesterol 
•semi-purified diet designed for 5% fat level. 
bSemi-purified diet designed for 20% fat level. 
High 
Chol 
50 
20 
14.6 
0.03 
4 
1.1 
5 
5 
0.25 
Hi!!h Fat Dietb 
Fish Oil Diet Mix Diet< 
Low High Low High 
Chol Chol Chol Chol 
30.5 30.5 30.5 30.5 
20 20 20 20 
19 19 19 19 
0.03 0.03 0.03 0.03 
4 4 4 4 
1.1 1.1 1.1 1.1 
5 5 5 5 
20 20 20 20 
0.1 0.25 0.1 0.25 
cMix diet, semi-purified diet (MP Biomedicals # 960241) supplemented with lard and safflower-seed oil. 
dComponents were from MP Biomedicals, Solon, OH, USA. 
•supplied in adequate amounts to meet requirement (National Research Council, 1995). AIN-76 Mineral 
mix ;Vitamin mix (MP Biomedicals # 904654). 
rCellulose was supplied as Alphacel non-nutritive bulk (MP Biomedicals, Solon, OH, USA). 
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Table 2.2 Fatty Acid Composition of the Diets (%, w/w). 
Lipids were extracted from the diets and the fatty acid composition of the diets was 
determined by gas-liquid chromatography (GLC) using a Hewlett Packard 5890 
instrument equipped with a flame ionization detector (FID). Methyl esters were prepared 
as described in Keough et al. (1979). 
Fatty acids Fish oil 
14:0 9.6 
16:0 19.3 
16:1 n7 13.1 
18:0 3.8 
18:1 n9 13.8 
18:2 n6 2.7 
18:3 n3 4.5 
18:4 n3 3.4 
20:1 n9 1.6 
20:4 n6 1.0 
20:5 n3 12.9 
22:5 n3 2.4 
22:6 n3 12.0 
L:SFA 32.0 
L:MUFA 28.0 
L:PUFA 38.0 
L:n-3 PUFA 35.0 
L:n-6 PUFA 3.0 
I: SF A, sum of saturated fatty acids. 
L:MUF A, sum of monounsaturated fatty acids. 
L:PUF A, sum of polyunsaturated fatty acids. 
ND, not detected. 
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Mix 
1.0 
19.3 
2.0 
10.0 
31.0 
34.0 
3.0 
ND 
ND 
ND 
ND 
ND 
ND 
30.0 
32.0 
37.0 
3.0 
34.0 
decided to terminate the experiments at two weeks of feeding. All animals were 
sacrificed after 14 hours fasting (9:00am). The livers were removed and quick frozen in 
the liquid nitrogen and stored at -70°C until further use. 
2.2 Preparation of Microsomes from Hamster Livers. 
Approximately 300mg of hamster liver was homogenized with 3ml ice-cold buffer I 
(50mM KCl, 1mM EDTA, 100mM K2HP04 (pH 7.4), 50mM KF, 5mM Dithiothreitol 
(DTT), 300mM sucrose) and centrifuged at 9,000rpm (9,800g) at 4°C for 20 minutes 
(Beckman JA-20 rotor). The fat on the top of the supernatant was removed. The 
supernatant was then centrifuged at 35,000rpm (150,000g) at 4°C for 70 minutes 
(Beckman SW 55 Ti rotor). The microsomal pellets were resuspended with 500Jll of 
buffer II (50mM KCl, 1mM EDTA, lOOmM K2HP04 (pH 7.4), 50mM KF and 50mM 
DTT). All procedures were performed at 4°C. 
2.3 HMG-CoA Reductase Activity Assay. 
The HMG-CoA reductase activity was determined to be linear from 0-400ug of 
protein. The hamster liver microsomes with 0.3mg of protein were first mixed with 0.5 
mM DTT and 2X CYP7 assay buffer (200mM K2HP04, pH 7.4, 2mM EDTA-K2, 100mM 
KF) to bring the volume to 100Jll and preheated to 37°C for 5 minutes. Incubations were 
carried out by adding 50 ,ul of a substrate mixture containing 0.1 ,uCi of3-Hydroxy-3-
methyl [3-14C] glutaryl-coenzyme A (50-62mCi/mmol), 50 nmol ofDL-3-Hydroxy-3-
methylglutaryl coenzyme A, 0.4 ,umol NADP, 0.6U ofGlucose-6-Phosphate 
Dehydrogenase, 5.3 ,umol ofP-D-Glucose 6-phosphate, 0.09M EDTA-K2, 0.15M 
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K2HP04, pH 7.4, 0.068M KF, and incubated in a 37°C water bath. After 25 minutes, the 
reaction was stopped by adding 20 ,ul of 5N HCl and kept at 37°C for another 30 minutes 
to assure lactonization of the mevalonate (Panini et al., 1984). The denatured proteins are 
then removed by centrifugation (12,000g /5min). 150,ul of supernatant was transferedto a 
micro tube containing lO,ul of0.77M mevalonic acid lactone. The supernatants were 
spotted at one inch from the bottom on Whatman glass TLC plates (K6 Cilica Gel). The 
plates were developed in acetone-benzene (1: 1) until the solvent front was within 1 em of 
the top edge of the plate. After the lipids were visualized using iodine vapor, the C14-
mevalonic acid lactone was identified by comparision with a mevalonic acid lactone 
standard. After complete removal of iodine the mevalonic acid lactone band was scraped 
from the plate and counted in a liquid scintillation counter (LKB Model1214 Rackbeta). 
2.4 CYP-7 Activity Assay 
Cpy-7 enzyme activity in purified microsomes was assayed using a modification of 
previously described method using isotope incorporation into 7a-hydroxy cholesterol 
(Martinet al., 1993). In the assay, [14C] cholesterol (53.10mCi/mmol) (0.04mCi/ml) 
encapsulated in 2-hydroxypropyl-B-cyclodextrin (Sigma) was used as a substrate. In a 
total volume of250ul, each assay tube contained 100mM K2P04, PH 7.4, 1mM EDTA-
K2, 50mM KF, 1mM NADPH, [14C] cholesterol (0.0612 uCi), 4.5 ug cholesterol, 
2.205mg cyclodextrin, 300ug microsome protein. Before adding NADPH, the assay tubes 
containing all components were preincubated on ice. The tubes were prewarmed in a 
37°C water bath for 3min, and the assay started with addition ofNADPH and incubated 
at 37°C for 15min. The reaction was stopped with 20ul of 5M NaOH. The final product, 
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7a-hydroxycholesterol, was extracted with ethyl acetate and separated from the reaction 
mixture by thin-layer chromatography using an ethyl acetate-toluene (3:2 v/v) solvent 
system. The product spot was visualized by iodine vapor and scraped from the plate. The 
amount of radioactivity in the spots corresponding to [14C] 7a-hydroxycholesterol was 
counted using scintillation counter (LKB Model1214 Rackbeta). Calculation of enzyme 
activity took into account the dilution (C14-Chol/Chol=6.22dpm/pmol) of the exogenous 
labeled cholesterol by the endogenous cholesterol in the microsome. 
2.5 ACAT Activity Assay 
ACAT activity in microsome fractions was determined using the modified isotope 
method as described previously (Stahlberg et al., 1989). Each ACA T assay reaction 
mixture contains 0.1 mg microsomal protein, 1.0 mg bovine serum albumin (Sigma), and 
cholesterol emulsion with 23 ug (59 nmol) cholesterol (Sigma) and 230ug 
phosphatidylcholine, 2mM DTT, O.lM K2HP04 in a total volume of 50ul. The mixture 
was incubated in a 37°C water bath for 30 min. The reaction was started with additional 
C14-oleoyl CoA plus 0.2mg cold oleoyl CoA in a 2 ul volume into the mixture and 
incubated at 37°C for 20 min. After terminating the reaction with additional200ul of 
chloroform/methanol (2:1) mixture, the final product, cholesteryl-C14-oleate, was 
extracted with chloroform/methanol mixture (2:1). The C14-cholesterol ester was 
separated by thin-layer chromatography (peteroleum ether: diethyl ether: acetic acid= 
90:10:1 ). After the lipids were visualized using iodine vapor, and the cholesteryl ester 
was identified by comparision with a cholesteryl ester standard. After complete removal 
of iodine the cholesteryl-ester bands were scraped from the plate and counted. 
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2.6 RT -PCR Assay for HMG-CoA Reductase mRNA Level. 
The total RNA was isolated from hamster liver by using FastRNA kit, and the 
FastPrep FP120 instrument, following the kit's protocol (Qbiogene, Carlsbad, CA). 
The purity of the RNA was checked by running the samples on a 1% agarose gel in 
borate buffer. The mRNA level ofHMG-CoA reductase was determined by reverse 
transcription and amplified by PCR. The complementary DNA was synthesized from the 
liver RNA (2J.Lg) using Superscript™ reverse transcriptase (from Invitrogen) and was 
used as the template for PCR amplification. The primers for HMG-CoA reductase were 
purchased from Sigma-Aldrich and were as follows: sense 5'-
CCTCTCCACAAAGCTTCCAG-3 ', and antisense 5'-
CAGAATCACAAGCACGAGGA-3' (accession#: M12705). The HMG-CoA reductase 
mRNA levels were normalized to P-actin mRNA levels. The primers used for P-actin 
were: sense 5'-CATCGTACTCCTGCTTGCTG-3', and antisense 5'-
GCTACAGCTTCAC-CACCACA-3'. After PCR amplification, the products were 
resolved on a 1.5% agarose gel. The bands were quantified using the Chemilmager™ 
4400 gel documentation system (Alpha Inotech Corporation, San Leandro, CA). 
2.7 The Western Blot Assay for SREBP-2. 
The frozen liver samples were first homogenized in SDS sample buffer (62.5mM 
Tris-base, 2% SDS, 10% glycerol and 50mM DTT), and amount of protein in the liver 
lysate was quantified by Lowry assay after TCA precipitation. The samples (60J.Lg) were 
boiled and loaded on a 1 0% SDS-polyacrylamide gel. The separated proteins were 
transferred to a nitrocellulose membrane (0.2um) (Bio-Rad Laboratories, Inc., Hercules, 
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CA). The primary antibody, goat polyclonal IgG, SREBP-2 (N-19), and the secondary 
antibody, bovine anti-goat IgG-HRP, were used to detect theN-terminal of SREBP-2. 
SREBP-2 (1C6), the mouse monoclonal IgGI, and bovine anti-mouse IgG-HRP were 
used to detect the C-terminal of SREBP-2. All antibodies were purchased from Santa 
Cruz Biology Inc (Santa Cruz, CA). Protein mobilities were compared with molecular 
weight standards (New England BioLab Inc., Ipswich, MA). The protein bands were then 
visualized through the chemiluminescent method (Bio-Rad Laboratories, Hercules, CA) 
2.8 Quantitation of Microsomal Cholesterol 
The microsomal free cholesterol concentration was determined by a previous method 
(Rudel and Morris, 1973). Briefly, an appropriate amount of microsome (50ul, ~250-
400ug protein) was extracted with 220 ul chloroform: methanol mixture (1: 1, v/v) and 
back washed with 50 ul of water. After the extract was centrifuged at 12,000g for 2min, 
the top layer water was taken off, and the bottom layer solvent was dried with nitrogen. 
The assay started with adding 900 ul o-phthalaldehyde (0.5mg/ml acetic acid) and 
450 ul concentrated H2S04, to the dried cholesterol and mixed well. After 30min, the 
absorbance was measure at 550nm. A series of cholesterol standard (0-50nmol) was used 
and produced a linear relationship between cholesterol concentration and the absorbance 
at 550nm. 
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2.9 Quantitation of Microsomal Phospholipid and Fatty Acids 
The method used for fatty acid extraction and analysis was previously described 
(Keough and Davis, 1979). Briefly, the microsomal lipids were extracted as described for 
cholesterol and transmethylated with 6 % H2S04 in methanol. After heating samples at 
90°C for 5 hours, the fatty acid methyl esters (FAME) were extracted twice with hexane 
and wash with water. The extracts were dried with nitrogen and ~ 1 Oul CS2 was added 
before injection onto a supelcowax 10 capillary column in an HIP 5890 gas 
chromatograph. The column program was set at 170°C for 2 minutes and heating from 
172°C to 220°C at a rate of2°C per minute for 27 minutes. The FAME were detected 
using a FID and identified by retention time. 
The method used for phospholipids analysis was previously described (Parrish, 1999). 
Briefly, an appropriate amount of lipid extract (~7ul) was spotted on chromarods (quartz 
rod coated with a thin layer of silica) and developed in acetone 5 min for focusing the 
sample spots, dried and developed for another 7 min to separate the phospholipids from 
neutrolipids, which were removed by burning in a hydrogen flame. After condition for 2 
min, the remaining phospholipids were focused and developed in a polar solvent mixture 
(chloroform: methanol: water= 70: 35: 3.5). The rods were scanned in an Iatroscan Mark 
V analyzer (latron Laboratories, Tokyo, Japan) and the three chromatograms were 
combined using T -data scan software (RSS, Bemis, TN). The signal was quantified using 
lipid standards (Sigma Chemical Company, St. Louis, MO). 
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2.10 Statistical Analysis 
Data are presented as group means± SD, where n=6 unless otherwise noted. 
Differences due to the dietary fat amount, fat types, cholesterol, and interactions were 
determined by three-way analysis of variance (ANOV A) via using the software, 
Sigmaplot-1 0. Linear regression was used to assess significant correlations between 
variables. A P-value ofless than 0.05 was considered significant. 
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Chapter 3. Results 
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3.1 Food Consumption and Hamster Body Weight 
Food consumption measurements indicated no change in food intake in hamsters 
fed the various diets (de Silva, 2003). There was no significant effect of dietary fat levels 
or diet types on body weight gain in the two week period. However there was a 
significant increase in liver weight in hamsters fed the high fat diet compared to hamsters 
fed the low fat diet irrespective of the diet types. 
This work forms part of a pilot study and two weeks was selected as an initial 
feeding period. It has already been reported that the plasma lipid concentrations 
dramatically increased in the fish-oil-fed hamsters after two weeks of feeding. Moreover, 
red blood cells from fish oil diet-fed hamsters showed increased levels ofEPA and DHA 
at the expense oflinoleic acid (18:2 n-6) and arachidonic acid (20:4 n-6) compared to 
MIX diet-fed hamsters. Thus, the length of the experimental feeding period was sufficient 
to induce significant changes in the fatty acid composition of the tissues and these 
changes reflected dietary lipid intake (de Silva, 2003). 
3.2 HMG-CoA Reductase Activity 
Figure 3.1 shows the activity ofHMG-CoA reductase in the livers of hamsters fed 
varying amounts of either a fish oil diet or a MIX diet, in the presence of 0.1% or 0.25% 
cholesterol for two weeks. The additional cholesterol supplement had a significant effect 
(P<0.05) on suppressing the hepatic activity in FIB hamsters, regardless of the types or 
amount of the fat in the diets. However the difference in activity in the microsomes of 
animals fed different diets was very modest, especially in those fed high fat fish oil diets. 
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Figure 3.1 The Dietary Effects on Hepatic HMG-CoA Reductase Activity in FIB 
Hamsters. 
The activity ofHMG-CoA reductase was affected significantly by dietary cholesterol 
treatment only. Hamsters were fed either a fish oil supplemented diet or a control diet 
supplemented with a mixture oflard and safflower-seed oil (MIX diet), at low fat (5%, 
w/w) or high fat (20%) levels, in the presence of0.1% (Grey bars) or 0.25% (Black bars) 
(w/w) cholesterol respectively for two weeks. Mean values are shown, with standard 
deviations indicated by vertical bars (n=6 in low fat diets, n=5 in high fat diets). 
Differences between groups were evaluated using 3 way ANOV A analysis with Holm-
Sidak method. 
Three-way analysis of variance (ANOVA) on HMG-CoA reductase Activity 
Source of Variation DF ss MS F p 
Amount of fat (A) 1 138.2 138.2 2.931 0.096 
Type of fat (B) 1 3.285 3.285 0.0697 0.793 
-/+ Cholesterol (C) 1 201.933 201.933 4.282 0.046 
AXB 1 72.409 72.409 1.536 0.224 
AXC 1 122.929 122.929 2.607 0.116 
BXC 1 25.494 25.494 0.541 0.467 
AXBXC 1 33.663 33.663 0.714 0.404 
Residual 34 1603.239 47.154 
Total 41 2253.123 54.954 
DF- Degrees of Freedom F - F Distribution 
SS- Sum ofthe Squares P -p value 
MS - Mean Squares 
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3.3 mRNA Level of HMG-CoA Reductase 
Figure 3.2 shows the mRNA levels ofHMG-CoA reductase in the livers of FIB 
hamsters fed the designed diets for two weeks. Although the mRNA slightly increased 
when dietary cholesterol is added, the difference was not statistically significant; thus, the 
dietary interaction had no effect on the mRNA expression. 
3.4 CYP7 Activity 
Figure 3.3 shows the activity of hepatic CYP7 in FIB hamsters fed various diets for 
two weeks. The activity was significantly reduced (P<0.05) when the proportion of the 
dietary fat was increased from 5% to 20%, but the types of the polyunsaturated fatty acids, 
n-3 and n-6, in the diet, and the additional dietary cholesterol had no effect on the CYP7 
activity. 
3.5 Dietary Effects on Hepatic ACAT Activity 
The effects of diet on the levels of Acyl Coenzyme A: Cholesterol Acyltransferase 
(ACAT) activity in the microsome from FIB hamsters is shown in Figure 3.4. The results 
revealed that addition of cholesterol to the diet of the animals had a significant effect on 
ACAT activity (P<0.05). The effect was most pronounced in the animals fed a high fat 
diet where increasing the dietary cholesterol from 0.1% to 0.25% resulted in a marked 
increase in ACAT activity by 2.5 fold and 1. 7 fold for hamsters fed the fish oil and MIX 
diets respectively. This is reflected in the results from low and high fat diets that shows a 
significant interaction of dietary fat level and cholesterol content (P<O.OOI ). Interestingly 
the effect of dietary cholesterol on ACA T activity in hamsters fed high 
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Figure 3.2 The Dietary Effects on The Expression of Hepatic HMG-CoA mRNA in 
Fl B Hamsters. 
Diet composition had no significant impact on the mRNA expression of hepatic 
HMG-CoA reductase in FIB hamsters. The animals were fed either a fish oil 
supplemented diet or a control diet supplemented with a mixture of lard and MIX diet, at 
low fat (5%, w/w) or high fat (20%) levels, in the presence ofO.l% (Grey bars) or 0.25% 
(w/w) (Black bars) cholesterol for two weeks. Total hepatic RNA was extracted, then 
reverse transcribed and then the eDNA templates of the reductase and 13-actin were 
amplified. The amount of amplified templates were quantified and the abundance of 
HMG-CoA reductase mRNA was expressed relative to 13-actin mRNA. Mean values are 
shown, with standard deviations indicated by vertical bars (n=3). The lack of the error 
bars is due to insufficient data (n=2). Effects ofthe diets were evaluated using 3 way 
ANOV A analysis with Holm-Sidak method. 
Three-way analysis of variance (ANOV A) on HMG-CoA reductase mRNA level 
Source ofVariation DF ss MS F p 
Amount of fat (A) 1 0.0375 0.0375 0.375 0.55 
Type of fat (B) 1 0.0173 0.0173 0.173 0.683 
-/+ Cholesterol (C) 1 0.202 0.202 2.019 0.176 
AXB 1 0.156 0.156 1.564 0.23 
AXC 1 0.0221 0.0221 0.222 0.645 
BXC 1 0.0476 0.0476 0.476 0.501 
AXBXC 1 0.0513 0.0513 0.513 0.485 
Residual 15 1.499 0.0999 
Total 22 2.143 0.0974 
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Figure 3.3 The Dietary Effects on The Expression of Hepatic CYP7 Activity in FlB 
Hamsters. 
The hepatic CYP7 activity in FIB hamsters fed various diets was suppressed by the 
increased amount of fat in the diets. The types of the dietary fats and cholesterol 
supplement had no effect on the activity. The animals were fed either a fish oil 
supplemented diet or a control diet supplemented with a mixture oflard and MIX diet, at 
low fat (5%, w/w) or high fat (20%) levels, in the presence of 0.1% (Grey bars) or 0.25 % 
(Black bars) (w/w) cholesterol, respectively, for two weeks. Mean values are shown, with 
standard deviations indicated by vertical bars (n=6 at low fat diet, n=5 at high fat diets). 
Effects of the diets were evaluated using 3 way ANOV A analysis with Holm-Sidak 
method. 
Three-way analysis of variance (ANOV A) on CYP7 activity 
Source ofVariation DF ss MS F p 
Amount of fat (A) 1 2722.766 2722.766 9.894 0.003 
Type of fat (B) 1 442.726 442.726 1.609 0.213 
-/+ Cholesterol (C) 1 616.885 616.885 2.242 0.143 
AXB 1 862.389 862.389 3.134 0.085 
AXC 1 5.81 5.81 0.0211 0.885 
BXC 1 162.183 162.183 0.589 0.448 
AXBXC 1 3.636 3.636 0.0132 0.909 
Residual 35 9631.645 275.19 
Total 42 14458.421 344.248 
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Figure 3.4 The Dietary Effects on The Hepatic ACAT Activity in F1B Hamster 
Overall, dietary cholesterol induced a significant increase on the hepatic ACAT 
activity (P<0.05). Moreover, this regulation of dietary cholesterol has a combination 
effect with the proportion and types of the dietary fats respectively (P<0.001 and P<0.05 
respectively). The animals were fed either a fish oil supplemented diet or a control diet 
supplemented with a mixture oflard and safflower-seed oil (MIX) diet, at low fat (5%, 
w/w) or high fat (20%) levels, in the presence of0.1% (Grey bars) or 0.25% (Black bars) 
(w/w) cholesterol respectively for two weeks. Mean values are shown, with standard 
deviations indicated by vertical bars (n=6 at low fat diet, n=5 at high fat diets). 
Differences between groups were evaluated using 3 way ANOV A analysis with Holm-
Sidak method. 
Three-way analysis ofvariance (ANOVA) on ACAT activity 
Source of Variation DF ss MS F p 
Amount of fat (A) 1 15397.76 15397.76 1.2 0.283 
Type of fat (B) 1 17380.372 17380.372 1.354 0.255 
-/+ Cholesterol (C) 1 56267.971 56267.971 4.385 0.046 
AXB 1 14342.023 14342.023 1.118 0.3 
AXC 1 307650.603 307650.603 23.975 <0.001 
BXC 1 90094.272 90094.272 7.021 0.014 
AXBXC 1 217.173 217.173 0.0169 0.897 
Residual 26 333640.038 12832.309 
Total 33 839526.738 25440.204 
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diets appeared to be regulated differently when the animals were fed low fat diets, 
resulting in reduction of the activity, especially in animals fed MIX diets. 
The analysis also shows a significant interaction between dietary cholesterol and the 
types of the dietary fat (P<0.05). In the presence of additional cholesterol, the ACAT 
activity was higher when the hamsters were fed fish oil diets (n-3 rich), compared to 
animals fed MIX diets (n-6 rich). Without additional dietary cholesterol, the MIX diets 
appeared to raise the activity slightly higher than animals fed fish oil diets. It is also 
interesting that the ACAT activity in microsomes from hamsters fed a chow diet 
approximates that for animals fed the low fat fish oil diet. 
3.6 The Dietary Effects on The Expression of Hepatic SREBP-2 in FlB Hamsters 
Here we used two antibodies N-19 and 1C6, which are against the N-and C-terminal 
respectively of the SREBP-2, to evaluate the expression of the mature and precursor 
forms of the protein. The band's intensity was normalized with the band of low fat fish 
oil diet in the same Western gel. Figure 3.5 shows the Western picture of the hamster 
liver lysate running in the same gel, but using antibodies N-19 (left) and 1C6 (right) 
respectively. Interestingly we found that the 1 C6 might cross-react with the mature form 
of the SREBP-2, because the right picture also has a series ofbands with molecular 
weight (~70 KDa) very close to the bands of mature form ofSREBP-2 using antibody 
N-19. Therefore, we also quantitated those bands as mature SREBP-2. In Figure 3.6 and 
Figure 3. 7, the variations of the diets had no significant influence on the expression of 
either the precursor or mature forms of the hepatic SREBP-2 in F1B hamsters. However, 
in Figure 3.7, the precursor forms are significantly reduced when the animals were fed 
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Figure 3.5 The Cross-Reaction of Antibody 1C6 on The Mature SREBP-2 
This figure shows that the antibody 1C6 might cross-react with the mature form of the 
SREBP-2 by showing bands very close to the position (68 KDa) where the N-19 attached 
to the mature form, when the proteins were running in the same gel but developed 
separately. 
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Figure 3.6 The Dietary Effects on the Expression ofSREBP-2 Using Antibody N-19 
The diets had no significant effect on the expression of either the precursor or mature 
forms ofSREBP-2 using antibodyN-19. The animals were fed either a fish oil 
supplemented diet or a control diet supplemented with a mixture of lard and safflower-
seed oil (MIX) diet, at low fat (5%, w/w) or high fat (20%) levels, in the presence of 
0.1% or 0.25 % (w/w) cholesterol respectively for two weeks. The black and grey bars 
represent the precursor and mature forms of SREBP-2. The lack of the error bar is due to 
n=2 of the precursor data, but n=3 in mature form data. Mean values are shown, with 
standard deviations indicated by vertical bars (n=3). Differences between groups were 
evaluated using 3 way ANOV A analysis with Holm-Sidak method. 
Three-way analysis of variance (ANOVA) on SREBP-2 using N-19 
Source ofVariation DF ss MS F p 
Amount of fat (A) 1 4443.696 4443.696 1.367 0.259 
Type of fat (B) 1 1922.643 1922.643 0.592 0.453 
-/+ Cholesterol (C) 1 4388.068 4388.068 1.35 0.262 
AXB 1 2374.316 2374.316 0.731 0.405 
AXC 1 3047.673 3047.673 0.938 0.347 
BXC 1 3214.988 3214.988 0.989 0.335 
AXBXC 1 4.659 4.659 0.00143 0.97 
Residual 16 52000.158 3250.01 
Total 23 71396.201 3104.183 
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Figure 3.7 The Dietary Effects on the Expression of The SREBP-2 Using Antibody 
1C6 
The diets had no significant effect on the expression of mature forms of SREBP-2 
using antibody 1 C6, however the precursors were significantly reduced when the animals 
were fed MIX diets as compared to the FO diet groups. The animals were fed either a fish 
oil supplemented diet or a control diet supplemented with a mixture of lard and 
safflower-seed oil (MIX) diet, at low fat (5%, w/w) or high fat (20%) levels, in the 
presence of 0.1% or 0.25 % (w/w) cholesterol respectively for two weeks. Mean values 
are shown, with standard deviations indicated by vertical bars (n=3). Effects of the diets 
were evaluated using 3 way ANOV A analysis with Holm-Sidak method. 
Three-way analysis ofvariance (ANOVA) on SREBP-2 using 1C6 
Source of Variation DF ss MS F p 
Amount of fat (A) 1 218.844 218.844 0.332 0.572 
Type of fat (B) 1 391.806 391.806 0.594 0.452 
-/+ Cholesterol (C) 1 229.467 229.467 0.348 0.563 
AXB 1 21.346 21.346 0.0324 0.859 
AXC 1 137.277 137.277 0.208 0.654 
BXC 1 39.344 39.344 0.0597 0.81 
AXBXC 1 45.941 45.941 0.0697 0.795 
Residual 16 10546.212 659.138 
Total 23 11630.238 505.663 
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the MIX diets compared to those fed the FO diets. The reason why different antibodies 
showed different expression of the precursor is not clear. 
Due to the insufficient data number, the data were pooled together in three ways, 
FO versus MIX diet, low fat versus high fat diets, without versus with dietary cholesterol, 
and analyzed by one way Anova. The analysis results show that the variations of the diets 
had no significant effect on the SREBP-2 expression. 
3. 7 The Dietary Effect on The Hepatic Microsome Cholesterol Concentration in 
FlB Hamster 
Figure 3.8 shows the cholesterol concentration in the liver microsome ofFlB 
hamsters fed various diets for two weeks. The additional cholesterol supplement alone 
had no impact on the microsomal cholesterol concentration. On the other hand, the types 
and the amount of the dietary fats individually had a significant effect (P<0.05 and 
P<O.Ol respectively) on the cholesterol levels in this organelle. The results show that the 
high fat or the fish oil (n-3 rich) diets increased the cholesterol concentration in the 
hepatic micro somes of the hamsters. 
The statistical analysis also shows a significant interaction between the dietary 
cholesterol and the amount of the dietary fats (P<0.05), resulting in an elevated 
concentration of cholesterol when hamsters were fed cholesterol and high fat diets, 
compared to animals fed high fat diets without dietary cholesterol. However, when 
hamsters were fed with low fat diets, the effect of dietary cholesterol on the levels of 
microsomal cholesterol was not as great as that seen in high fat groups, and was even 
lower in animals fed low fat MIX diet. 
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Fig 3.8 The Dietary Effects on The Microsome Cholesterol Concentration in FlB 
Hamsters 
The high fat and the n-3 rich diets individually induced a significant increase of the 
concentration of microsomal cholesterol in F1B hamsters. The dietary cholesterol had no 
significant effect on the microsomal cholesterol. The statistical analysis also showed a 
significant interaction between dietary cholesterol and high fat diets, resulting in 
increased microsomal cholesterol in the hamsters. The animals were fed either a fish oil 
supplemented diet or a control diet supplemented with a mixture of lard and safflower-
seed oil (MIX) diet, at low fat (5%, w/w) or high fat (20%) levels, in the presence of 
0.1% (Grey bars) or 0.25 %(Black bars) (w/w) cholesterol respectively for two weeks. 
Mean values are shown, with standard deviations indicated by vertical bars (n=6 at low 
fat diet, n=5 at high fat diets). Effects of the diets were evaluated using 3 way ANOV A 
analysis with Holm-Sidak method. 
Three-way analysis of variance (ANOV A) on microsomal cholesterol level 
Source ofVariation DF ss MS F p 
Amount of fat (A) 1 558.653 558.653 7.945 0.012 
Type of fat (B) 1 631.057 631.057 8.974 0.009 
-/+ Cholesterol (C) 1 176.911 176.911 2.516 0.132 
AXB 1 25.922 25.922 0.369 0.552 
AXC 1 347.383 347.383 4.94 0.041 
BXC 1 16.781 16.781 0.239 0.632 
AXBXC 1 259.524 259.524 3.691 0.073 
Residual 16 1125.091 70.318 
Total 23 3141.321 136.579 
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Figure 3.9 shows a regression analysis between the microsomal cholesterol and the 
activities of the three microsomal enzymes, HMG-CoA reductase, CYP7, and ACAT, in 
FlB hamsters fed different diets for two weeks. The data for the activities and the 
concentration of microsomal cholesterol were obtained within the same animals. The 
activities ofHMG-CoA reductase and the CYP7 had no correlation with the microsomal 
cholesterol (R2 :::::; 0). The ACAT activity, on the other hand, showed a significant 
correlation with the concentration of the microsomal cholesterol (P<0.05; R2 = 0.31). 
When comparing Figure 3.4 and Figure 3.8, we found that the variations ofthe diets 
had a similar impact on both the ACAT activity and the concentration of the microsomal 
cholesterol in FlB hamster liver, which showed a greater influence on ACAT activity 
than on cholesterol concentration. This may suggest that the increased cholesterol 
concentration, caused by the dietary variation, in the hepatic microsome of the hamsters 
greatly promotes the ACAT activity, which results in only a slight increase of cholesterol 
in the hepatic microsome ofFlB hamsters. 
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Figure 3.9 The Effect of Microsomal Cholesterol Concentration on The Hepatic 
Enzyme Activities in FlB Hamster. 
The concentration of the microsomal cholesterol was significantly correlated (P<0.05, 
R2 ~ 0.31) with the microsomal ACAT activity, but not with HMG-CoA reductase and 
CYP7, in FIB hamster liver. A regression analysis was performed to evaluate the 
correlation between the microsomal cholesterol concentration and the activities ofthe 
enzymes, HMG-CoA reductase, CYP7, and ACAT. The data of the activity and the 
concentration of microsomal cholesterol were obtained within the identical animals. The 
black dot, white dot, and the triangle represent the specific activity ofHMG-CoA 
reductase, CYP7, and ACAT, respectively, of the same animal with corresponding 
cholesterol concentration in the hepatic microsome. 
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3.8 The Dietary Effects on The Microsomal Fatty Acids Composition in FlB 
Hamster Liver 
Figure 3.10 shows the fatty acid composition of total microsomal lipids in the livers 
ofF1B hamsters fed different diets for two weeks. The total fatty acids were separated 
into 3 groups, saturated fatty acids (SATs), monounsaturated fatty acids (MUPAs), and 
polyunsaturated fatty acids (PUP As) for simple illustration. The variations of the diets 
had no significant influence on the proportion of the MUP As and PUP As out of total 
fatty acids in the hepatic microsome ofthe hamsters. The high fat diets, however, induced 
a significant increase (P<0.05) in the proportion of the total SATs in the microsome. 
Interestingly, we found that the proportion of the total MUP As and PUP As was much 
lower and higher, respectively, in the hamsters fed the control diet, compared with those 
fed experimental diets, which is not what we had expected. 
Figure 3.11 shows the percentage of only microsomal n-3 and n-6 PUPAs in F1B 
hamster liver. When comparing among the three dietary factors individually, only the n-
3/n-6 ratio in the diet had a significant impact (P<0.05) on the amount of n-3 and n-6 in 
the hepatic microsome of the hamsters. There was an increase ofn-3 PUPAs in the 
microsome when the animals were fed fish oil diets (n-3 rich), and an increased n-6 
PUP As when the animals were fed the MIX (n-6 rich) diets. 
Figure 3.12 shows the ratio ofthe n-3 and n-6 PUPAs in the hepatic microsome of 
F1B hamsters fed various diets for two weeks. Only the dietary n-3/n-6 ratio in the diets 
had a significant influence (P<0.001) on the n-3/n-6 PUPAs ratio in the microsome. The 
ratio is high when the hamsters were fed fish oil diet, and low when feeding hamsters 
with MIX diets, regardless of the amount of the dietary fat and cholesterol in the diets. 
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Figure 3.13 shows a significant interaction between the cholesterol concentration 
and the content ofn-3 PUFAs in the hepatic microsome in FlB hamsters fed various diets 
for two weeks (P<0.05, R2= 0.224). This figure indicates that the content ofn-3 PUFAs 
in the microsome was not only affected by the types of dietary PUF As (shown in Figure 
3.12), but also correlated with the cholesterol levels in the microsome. It is suggested that 
when the cholesterol levels in the microsome increases due to the diet, more n-3 PUF As 
were needed for incorporation with cholesterol in the hepatic microsome ofFlB hamsters. 
This positive correlation may contribute to stabilize the environment of the microsome 
for proper enzyme activation. 
3.9 The Correlation of Microsomal n-3 Fatty Acids and Enzyme Activities 
Both Figure 3.14 and 3.15 show a positive correlstion between the content of 
microsomal n-3 and hepatic HMG-CoA reductase (P<0.05, R2=0.282), and ACAT 
activity (P<0.05; R2= 0.334) in the FlB hamster fed various diets for two weeks. 
Together, these results show that although the activity ofHMG-CoA reductase and 
ACAT were not regulated by the dietary fat directly, both activities are positively 
correlated with the level ofn-3 fatty acids in the hepatic microsome, which suggests that 
the microsomal environment may play a much more important role on cholesterol 
homeostasis rather than the diet in FlB hamster. 
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Figure 3.10 The Dietary Effects on The Microsomal Fatty Acids Composition in FlB 
Hamster Liver 
The diets had no significant influence on the proportion of the MUP As and PUP As as 
a proportion of total fatty acids in the hepatic microsomes of the FlB hamsters. The high 
fat diets, however, induced a significant increase (P<0.05) in the proportion of the total 
SATs in the microsomes. Interestingly, we found that the proportions of the total MUPAs 
and PUP As were much smaller and higher respectively in the hamsters fed the control 
diet, compared to those fed experimental diets. 
The total fatty acids were separated into 3 groups, saturated fatty acids (SATs; black 
bars), monounsaturated fatty acids (MUF As; dark grey bars), and polyunsaturated fatty 
acids (PUP As; light grey bars) for simple illustration. 
The animals were fed either a fish oil supplemented diet or a control diet 
supplemented with a mixture oflard and safflower-seed oil (MIX) diet, at low fat (5%, 
w/w) or high fat (20%) levels, in the presence ofO.l% or 0.25% (w/w) cholesterol 
respectively for two weeks. Mean values are shown, with standard deviations indicated 
by vertical bars (n=3). Effects of the diets were evaluated using 3 way ANOVA analysis 
with Holm-Sidak method. 
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Three-way analysis of variance (ANOVA) on microsomal SAT level 
Source ofVariation DF ss MS F p 
Amount of fat (A) 1 59.945 59.945 1.376 0.255 
Type of fat (B) 1 1.493 1.493 0.0343 0.855 
-/+ Cholesterol (C) 1 0.18 0.18 0.00413 0.949 
AXB 1 29.327 29.327 0.673 0.422 
AXC 1 13.214 13.214 0.303 0.588 
BXC 1 19.289 19.289 0.443 0.513 
AXBXC 1 0.0721 0.0721 0.00166 0.968 
Residual 20 871.11 43.555 
Total 27 990.499 36.685 
Three-way analysis of variance (ANOVA) on microsomal MUFA level 
Source ofVariation DF ss MS F p 
Amount of fat (A) 1 52.5 52.5 0.941 0.344 
Type of fat (B) 1 126.195 126.195 2.263 0.148 
-/+ Cholesterol (C) 1 0.905 0.905 0.0162 0.9 
AXB 1 22.159 22.159 0.397 0.536 
AXC 1 7.845 7.845 0.141 0.712 
BXC 1 8.725 8.725 0.156 0.697 
AXBXC 1 7.895 7.895 0.142 0.711 
Residual 20 1115.399 55.77 
Total 27 1341.257 49.676 
Three-way analysis of variance (ANOVA) on microsomal PUFA level 
Source of Variation DF ss MS F p 
Amount of fat (A) 1 0.141 0.141 0.0014 0.971 
Type of fat (B) 1 120.393 120.393 1.191 0.288 
-/+Cholesterol (C) 1 119.977 119.977 1.187 0.289 
AXB 1 4.355 4.355 0.0431 0.838 
AXC 1 67.881 67.881 0.672 0.422 
BXC 1 186.436 186.436 1.845 0.189 
AXBXC 1 4.26 4.26 0.0422 0.839 
Residual 20 2020.905 101.045 
Total 27 2504.781 92.77 
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Figure 3.11 The Dietary Effects on The n-3 And n-6 PUFAs in the Hepatic 
Microsome of FlB Hamster 
When comparing among the three dietary factors individually, only the type of the 
dietary fats (n-3 or n-6 rich) had a significant impact on the amount ofn-3 and n-6 
(P<0.01) in the hepatic microsomes of the hamsters. It was accompanied by an increase 
in n-3 PUF As in the microsomes when the animals were fed fish oil diets (n-3 rich), and 
an n-6 PUF As increase when the animals were fed the MIX (n-6 rich) diets. The animals 
were fed either a fish oil supplemented diet or a control diet supplemented with a mixture 
oflard and safflower-seed oil (MIX) diet, at low fat (5%, w/w) or high fat (20%) levels, 
in the presence ofO.l% (Grey bars) or 0.25 %(Black bars) (w/w) cholesterol respectively 
for two weeks. Mean values are shown, with standard deviations indicated by vertical 
bars (n=3). Effects of the diets were evaluated using 3 way ANOVA analysis with Holm-
Sidak method. 
Three-way analysis of variance (ANOV A) on microsomal n-3 fatty acids level 
Source ofVariation DF ss MS F p 
Amount of fat (A) 1 0.209 0.209 0.00449 0.947 
Type of fat (B) 1 1168.687 1168.687 25.096 <0.001 
-/+ Cholesterol (C) 1 66.518 66.518 1.428 0.246 
AXB 1 0.0779 0.0779 0.00167 0.968 
AXC 1 46.832 46.832 1.006 0.328 
BXC 1 138.162 138.162 2.967 0.1 
AXBXC 1 19.57 19.57 0.42 0.524 
Residual 20 931.361 46.568 
Total 27 2311.529 85.612 
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Three-way analysis of variance (ANOV A) on microsomal n-6 fatty acids level 
Source ofVariation DF ss MS F p 
Amount of fat (A) 1 1.181 1.181 0.0313 0.861 
Type of fat (B) 1 500.215 500.215 13.253 0.002 
-/+ Cholesterol (C) 1 25.123 25.123 0.666 0.424 
AXB 1 6.999 6.999 0.185 0.671 
AXC 1 0.705 0.705 0.0187 0.893 
BXC 1 0.59 0.59 0.0156 0.902 
AXBXC 1 5.396 5.396 0.143 0.709 
Residual 20 754.844 37.742 
Total 27 1311.781 48.584 
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Figure 3.12 The Dietary Effects on The Ratio ofn-3/n-6 PUFAs in the Hepatic 
Microsome of F1B Hamster 
The ratio of n-3/n-6 PUF As in the hepatic microsomes was significantly increased 
(P<O.OOI) when feeding fish oil diets to the FIB hamsters, regardless of the amount of 
dietary fat or cholesterol. The ratio was reduced when the hamsters were fed the MIX 
diets. 
The animals were fed either a fish oil supplemented diet or a control diet 
supplemented with a mixture oflard and safflower-seed oil (MIX) diet, at low fat (5%, 
w/w) or high fat (20%) levels, in the presence ofO.l% (Grey bars) or 0.25% (Black bars) 
(w/w) cholesterol respectively for two weeks. Mean values are shown, with standard 
deviations indicated by vertical bars (n=3). Effects of the diets were evaluated using 3 
way ANOV A analysis with Holm-Sidak method. 
Three-way analysis of variance (ANOV A) on the ratio of microsomal n-3/n-6 fatty 
acids 
Source of Variation DF ss MS F p 
Amount of fat (A) 1 0.000881 0.000881 0.00599 0.939 
Type of fat (B) 1 6.876 6.876 46.738 <0.001 
-/+ Cholesterol (C) 1 0.0651 0.0651 0.443 0.514 
AXB 1 0.00691 0.00691 0.047 0.831 
AXC 1 0.09 0.09 0.612 0.443 
BXC 1 0.235 0.235 1.599 0.221 
AXBXC 1 0.0731 0.0731 0.497 0.489 
Residual 20 2.942 0.147 
Total 27 10.157 0.376 
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Figure 3.13 The Correlation Between the Cholesterol Concentration And the n-3 
PUFAs in the Hepatic Microsome ofFlB Hamster 
Regression analysis between the cholesterol concentration and the n-3 PUF As in the 
hepatic microsomes ofFlB hamsters indicated a significant positive correlation between 
the cholesterol concentration and the n-3 PUF As in the hepatic microsomes in the 
hamsters fed various diets for two weeks (P<0.05; R2= 0.224). 
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Figure 3.14 The Correlation Between the HMG-CoA Reductase Activity And then-
3 PUFAs in the Hepatic Microsome ofFlB Hamster 
A regression analysis between the HMG-CoA reductase activity and the n-3 PUF As 
in the hepatic microsomes ofFlB hamsters indicated a significant positive correlation 
between the cholesterol concentration and the n-3 PUFAs in the hepatic microsomes in 
hamsters fed various diets for two weeks (P<0.05; R2= 0.282). 
70 
Correlation of Microsomal n-3 and HMG .. coA reductase Activity 
• 
-c 
-
• s 
0 
a. 
11 
E 
i ~ ~0 
., ... 
=.2 
"e 
•m 25 E 
C: 
-e 
=s 2(1 i • 
-
15 
% of n-3 of total FAs in microsome 
71 
Figure 3.15 The Correlation Between the ACAT Activity And the n-3 PUFAs in the 
Hepatic Microsome of FlB Hamster 
Regression analysis between the ACAT activity and the n-3 PUFAs in the hepatic 
microsomes of FIB hamsters indicated a significant positive correlation between the 
cholesterol concentration and the n-3 PUF As in the hepatic microsomes in the hamsters 
fed various diets for two weeks (P<0.05; R2= 0.334). 
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3.10 The Dietary Effects on The Hepatic Microsome Phospholipid Composition in 
FlB Hamster 
Figure 3.16 shows the percentage of phospholipid composition out of total 
phospholipids of the hepatic microsome in FlB hamsters. The differences due to diets 
were not significant. 
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Figure 3.16 The Dietary Effects on The Microsomal Phospholipid Composition in 
FlB Hamster Liver 
The effect of diet on the phospholipid composition in the microsome was not 
significant. The phospholipids are separated into three groups, phosphatidylethanolamine 
(PE; black bars), phosphatidylserine (PS; dark grey bars), and phosphatidylcholine plus 
sphingomyelin (PC+SPH; light grey bars). The figure shows the percentage of 
phospholipid composition out of total phospholipids of the hepatic microsome in FlB 
hamsters. 
The animals were fed either a fish oil supplemented diet or a control diet 
supplemented with a mixture oflard and safflower-seed oil (MIX) diet, at low fat (5%, 
w/w) or high fat (20%) levels, in the presence of 0.1% or 0.25 % (w/w) cholesterol 
respectively for two weeks. Mean values are shown, with standard deviations indicated 
by vertical bars (n=3), and the lack ofthe error bar is due to insufficient data number 
(n=2). Differences between groups were evaluated using 3 way ANOV A analysis with 
Holm-Sidak method. 
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Three-way analysis of variance (ANOV A) on microsomal PE 
Source of Variation DF ss MS F p 
Amount of fat (A) 1 117.813 117.813 4.363 0.055 
Type of fat (B) 1 56.333 56.333 2.086 0.171 
-/+Cholesterol (C) 1 76.339 76.339 2.827 0.115 
AXB 1 86.761 86.761 3.213 0.095 
AXC 1 70.406 70.406 2.607 0.129 
BXC 1 14.52 14.52 0.538 0.475 
AXBXC 1 43.828 43.828 1.623 0.223 
Residual 14 378.067 27.005 
Total 21 747.939 35.616 
Three-way analysis of variance (ANOV A) on microsomal PS 
Source ofVariation DF ss MS F p 
Amount of fat (A) 1 0.188 0.188 0.00248 0.961 
Type of fat (B) 1 35.938 35.938 0.475 0.502 
-/+Cholesterol (C) 1 20.367 20.367 0.269 0.612 
AXB 1 155.28 155.28 2.053 0.174 
AXC 1 108.601 108.601 1.436 0.251 
BXC 1 65.489 65.489 0.866 0.368 
AXBXC 1 29.978 29.978 0.396 0.539 
Residual 14 1059.012 75.644 
Total 21 1451.133 69.102 
Three-way analysis of variance (ANOV A) on microsomal PC+SPH 
Source ofVariation DF ss MS F p 
Amount of fat (A) 1 84.978 84.978 0.897 0.36 
Type of fat (B) 1 7.468 7.468 0.0789 0.783 
-/+ Cholesterol (C) 1 178.384 178.384 1.884 0.192 
AXB 1 3.557 3.557 0.0376 0.849 
AXC 1 3.853 3.853 0.0407 0.843 
BXC 1 18.089 18.089 0.191 0.669 
AXBXC 1 0.963 0.963 0.0102 0.921 
Residual 14 1325.897 94.707 
Total 21 1642.69 78.223 
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Chapter 4 Discussion 
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4.1 Dietary Fat and Cholesterol Homeostatsis 
Since the studies ofBang and Dyerberg on the lipoprotein profile of Greenland 
Eskimos in the 1970's, fish oil and other oils rich in n-3 PUFA have been proposed to 
offer protection against hyperlipidemia and CHD (Bang and Dyerberg, 1972; Dyerberg et 
al., 1975; Dyerberg et al., 1978). However, despite decades of animal studies and large 
scale human trails, the only consistent effect of dietary n-3 PUPAs has been reduced 
triglyceride levels in hypertriglyceridemic subjects (Connor, 1988; Connor et al., 1993; 
Hamazaki et al., 2003). Moreover, there is growing concern that diets rich in n-3 PUPAs 
may have a negative impact on patients with hypercholesterolemia (Failor et al., 1988; 
Hsu et al., 2000). Lin et al. reported recently that in hamsters with a low plasma 
cholesterol level, addition of n-3 PUF A to the diet results in a significant reduction in 
total plasma cholesterol, and in both VLDL and LDL cholesterol compared with animals 
fed an n-6 PUFA diet (Lin et al., 2005). However, when these animals were fed a diet 
containing 0.5% cholesterol (w/w), an n-3 diet group was more hypercholesterolemic 
than an n-6 diet group. This suggested that there was an interaction between the 
cholesterol mediated regulation of cholesterol metabolism and the regulation mediated by 
dietary fatty acids. 
Our laboratory has done similar studies using the inbred F1B hamster strain. This 
animal model has been used extensively because of its susceptibility to diet induced 
hyperlipidemia and atherosclerotic lesions (Kowala et al., 1991). An early study in our 
laboratory showed a clear difference between the response of the normal hamster to 
increased n-3/n-6 ratio in the diet and the response of the FlB strain to a similar change 
in the types of fatty acids in the diet. While Lin et al. (Lin et al., 2005) reported that 
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replacement ofn-6 PUPA in the diet of normal hamsters with n-3 PUPA reduced VLDL-
cholesterol by more than 60%, a similar change in dietary fatty acids in the FIB hamster 
resulted in a 4-5 fold increase in VLDL-cholesterol. 
When 0.5% (w/w) cholesterol was added to the diets ofthe normal hamster, there 
was a marked increase in the VLDL-cholesterollevels in the plasma, but in this case the 
n-3 diet resulted in a more hypercholesterolemic animal than the n-6 diet (Lin eta/., 
2005). In contrast, addition of cholesterol to the diets of the FIB hamsters resulted in a 
very modest change in VLDL-cholesterollevel in the plasma although the n-3 fed 
animals were still much more hypercholesterolemic than those fed n-6 PUP As (de Silva 
et al., 2004). These observations suggested that the regulation of cholesterol metabolism 
in the FIB hamster is different. 
The present study is an extension of our previous study that sought to investigate the 
cholesterol metabolism in the FIB hamster caused by different dietary PUF As and 
cholesterol at the hepatic cellular level. Our objective was to examine the regulation of 
cholesterol metabolism in the liver of FIB hamsters by both dietary cholesterol and the 
types and level of fatty acids in the diet. We looked at the expression of several 
microsome associated enzymes that play key roles in cholesterol metabolism in liver 
including, HMG-CoA reductase, CYP7, ACAT, a corresponding transcription factor, 
SREBP-2, and the lipid composition in the microsomes. 
4.2 Dietary Effects on Microsomal Enzyme Activity 
We found that dietary cholesterol down- and up-regulated the activity ofHMG-CoA 
reductase and ACAT respectively, but had no effect on CYP7 activity. This inducing 
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effect of dietary cholesterol on hepatic ACAT activity was correlated with the amount of 
dietary fat and fat types. (This suggests?) We also found that the cholesterol levels in the 
microsomes were increased when the hamsters were fed high fat and cholesterol 
supplemented diets. Moreover, the n-3 PUFA level was positively correlated with 
elevated cholesterol level in the microsomes. Thus we suggested that the dietary effects 
on enzyme activity and the cellular cholesterol homeostasis may be regulated by the 
fluidity of the microsomal membrane and the theoretical cholesterol pool in FIB hamster. 
4.2.1 Dietary Cholesterol and PUFAs on CYP7 Activity 
The activity of CYP7, the initial enzyme in the classic pathways of bile acid 
synthesis, is tightly regulated at the transcriptional level, since the activity is highly 
correlated with its mRNA levels (Agellon and Torchia, 2000;Russell and Setchell, 1992). 
Many studies have shown that the CYP7 gene expression is suppressed by bile acids and 
induced by cholesterol (Chiang eta/., 1990;Chiang and Stroup, 1994). 
However recent studies on African green monkeys and hyperlipidemic rabbits have 
shown that additional dietary cholesterol does not always stimulate the CYP7 activity as 
expected (Rudel eta/., 1994;Xu eta/., 1995). Studies on normal hamsters showed that the 
dietary unsaturated fats (linoleic acid and oleic acid) and saturated fat (palmitic acid) 
exert an opposite effect on the hepatic CYP7 activity when the hamsters were fed with 
0.1% dietary cholesterol (Kurushima eta/., 1995;Kurushima eta/., 1995). Studies in mice 
showed that, although different types of dietary fatty acids (PUF A, MUF A, SF A) all 
increase the CYP7 activity, the PUFA induced the highest activity among the dietary fats. 
Interestingly, when an additional 1% cholesterol was supplemented in the diets, the 
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dietary cholesterol further induced the CYP7 activity in animals fed the PUF A diets, 
while the activities were suppressed by additional cholesterol in hamsters fed the MUF A, 
SF A diets (Cheema et al., 1997). The results also showed that although the PUF A diets 
without dietary cholesterol induced the highest abundance on CYP7 mRNA, it was not 
associated with the highest activity. This fact implied that the dietary fats may regulate 
differently than at the transcriptional level. 
In our study, the CYP7 activity, surprisingly, was not affected by dietary cholesterol 
when supplemented in the polyunsaturated fat diets. The CYP7 activity was only affected 
by the amount of dietary fat, resulting in a reduction of the activity when the hamsters 
were fed the high fat diets. The reason why dietary cholesterol showed no effect on the 
activity was not clear. 
4.2.2 Dietary Cholesterol and PUF A on HMG-CoA Reductase Activtiy 
The rate limited enzyme of cholesterol biosynthsis, HMG-CoA reductase, and its 
feedback regulation has been studied for many years in different animal models. The 
reductase activity was suggested to be regulated differently depending on the animal's 
susceptibility to dietary cholesterol. Dietary cholesterol exerted feedback regulation 
mainly at the posttranslationallevel in rats that are relatively resistant to dietary 
cholesterol (Ness et al., 1991;Spady and Cuthbert, 1992) and at the transcriptional level 
in rabbits and hamsters that are relatively susceptible to dietary cholesterol (Gil et al., 
1986;Rudling, 1992). In our study, the hepatic HMG-CoA reductase activity was only 
affected by dietary cholesterol, resulting in a slight reduction of the activity when 
cholesterol was added to the diets. Although the extent of the reduction was not as great 
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as we expected and the mRNA levels were not affected by any ofthe dietary variations, 
these results suggested that the dietary cholesterol exerted the regulatory effect on the 
reductase activity at a level other than the transcription level. However, mRNA data 
include n=3, 2, so variability could be an issue. 
Although studies in mice (Duet al., 2003) and rats (Jossic-Corcos et al., 2005) 
showed that n-3 PUFA rich diets suppressed the hepatic HMG-CoA reductase activity 
and mRNA respectively much more than the n-6 PUF A rich diets without dietary 
cholesterol supplement, studies on hamsters showed that addition of dietary unsaturated 
fatty acids (linoleic acid or oleic acid) or saturated fatty acids (palmitic acid) to O.I% 
cholesterol-supplemented diets didn't alter the HMG-CoA reductase activityc in 
hamsters, compared with those fed cholesterol-supplemented diet (Kurushima et al., 
I995;Kurushima et al., I995). The results may suggest that the suppressing effect of 
dietary fat and cholesterol on the reductase activity is mainly due to the presence of 
cholesterol instead of dietary fats in hamsters. 
Our study also showed that the reductase activity in FIB hamster liver was only 
affected by the dietary cholesterol. This resulted in a marginal reduction of the activity 
regardless the types of the fats (n-3 or n-6). However, the mRNA levels of the reductase 
were not affected by the dietary cholesterol, which may suggest a non-transcriptional 
regulation on the hepatic HMG-CoA reductase in FIB hamsters. 
A recent study, in both rats and hamsters, showed that dietary PUF A (n-3, n-6) and 
cholesterol affected the cholesterol homeostasis differently in both serum and liver (Lin 
et al., 2005), clearly indicative of species differences between rat and hamster in response 
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to the interactive effects of dietary n-3 PUF A and cholesterol. This may partly explain 
why our results differ from those reported by others. 
4.2.3 Dietary Cholesterol and PUF As on Sterol Regulatory Element Binding 
Protein-2 
After we found that the dietary variation had no effect on the HMG-CoA reductase 
mRNA, we checked the expression ofthe transcription factor, SREBP-2, to see if it was 
regulated by dietary cholesterol and fats. Surprisingly, the levels of both the precursor 
and the mature form of the SREBP-2 in the livers ofF1B hamsters were not regulated by 
the dietary fat and cholesterol. 
According to the Brown and Goldstein model, the SREBPs are regulated by the 
cellular sterol and fatty acids levels through the SREBP-SCAP cascade (Brown and 
Goldstein, 1997e;Brown and Goldstein, 1999;Horton et al., 2002). The proteolytic 
maturation of the protein stops when the system senses high levels of sterol in the cell. 
However, this fact could not explain why the dietary cholesterol only slightly suppressed 
the HMG-CoA reductase activity without any changes on the reductase mRNA. 
Some studies have shown that the mature form of SREBP-2 can be slightly lower in 
mice fed a sardine oil-rich diet (Y ahagi et al., 1999) or by addition of arachidonic acid to 
rat hepatoma cells (Ou et al., 2001). The mRNA ofSREBP-2 was reduced in mouse 
liver by high fish oil diets. However, Jump et al. suggested that the PUF A only 
suppresses the mature form ofSREBP-1 but not SREBP-2 (Jump, 2002;Jump, 2004). In 
our case, the SREBP-2 was not regulated by the dietary PUF A. In summary, it appears 
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that the SREBP-SCAP cascade, the major regulatory system for cholesterogenesis, was 
not affected by the dietary composition in FlB hamster liver. 
4.2.4 Effect of Dietary Cholesterol and PUFAs on ACAT 
It has been shown that the level of acyl-CoA cholesterol acyltransferase (ACAT) 
activity is mostly controlled by the intracellular availability of sterol (Chang eta/., 
1995;Spady and Dietschy, 1988). Any physiological change that leads to a net increase 
in hepatic cholesterol induces the activity (Spady et a/., 1986), and similarly, any change 
decreasing the cholesterol in the liver suppresses the ACAT activity (Kovanen et a/., 
1981). However, other factors like allosteric regulation (Chang and Chang, 1986;Tabas 
and Boykow, 1987) and post-translational regulation (Matsuda eta/., 1996;Wang eta/., 
1996) have also been suggested to regulate ACAT. 
Although it is generally believed that free cholesterol drives the activity of ACAT, 
fatty acids have also been shown to alter the activity (Rumsey eta/., 1995). Studies in 
rats fed polyunsaturated fat suggested that the animals had more PUF A in the fatty acyl 
chains of the microsomal phospholipids, which was associated with higher hepatic ACAT 
activity compared to the animals fed saturated tristearin (Mitropoulos et a/., 1980). 
However, a study in the FIB hamster showed that the hepatic ACAT activity was slightly 
suppressed by the dietary unsaturated fatty acids, compared to those fed saturated fat 
diets, and with no difference in the activity when animals were fed the linoleic acid or 
oleic acid diets (Lee and Carr, 2004). This study may indicate an opposite effect of 
PUFA on the ACAT activity in F1B hamster that is different from other animal models. 
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A study in normal hamster showed that, in the presence ofO.I% dietary cholesterol, 
menhaden oil enriched diets induced the highest rate of cholesterol esterification 
compared with animals fed the diets rich either in corn oil, or olive oil, or coconut oil. 
This suggested a positive interaction between the dietary fish oil and cholesterol on the 
ACAT activity (Jones et al., I990). A study in mice also suggested that the dietary PUFA 
(safflower oil) further increases hepatic ACAT activity in the presence of I% dietary 
cholesterol. 
Although these studies suggested that dietary PUF A induce ACAT activity and 
additional cholesterol further increases the activity, the suppressing effect ofPUFA in 
FIB hamster may be regulated differently when the cholesterol is added to the diets. 
However, not many studies were focused on the interaction of the amount of the dietary 
fats, especially between the n-3 and n-6 fatty acids, and dietary cholesterol on the hepatic 
ACAT activity. In our study, the hepatic ACAT activity was induced by dietary 
cholesterol as we expected. Surprisingly, the amount of fat and types of fats (n-3, n-6) 
had no effect on the activity individually, but both factors have a positive interaction with 
dietary cholesterol. The high fat and fish oil rich diets induced the ACAT activity in FIB 
hamster when additional dietary cholesterol was added. However, without dietary 
cholesterol, increasing the amount of fat in both fish oil and MIX diets suppressed the 
ACA T activity compared to hamsters fed the low fat or even the control (chow) diets. 
This suggested that an opposite effect of dietary PUF A on ACAT activity in FIB 
hamster, dependent on the availability of dietary cholesterol. This fact implies that 
supplementation of diets with PUF A and cholesterol in hyperlipidemic subjects may not 
improve the serum lipid profile but rather it may induce higher ACAT activity, resulting 
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cholesterol ester accumulation in the liver and more VLDL-cholesterol ester secretion 
into the circulation and causing a severe hyperlipidaemia. Similar results were observed 
when normal hamsters were fed a diet with PUP As and cholesterol (Lin et al., 2005), and 
some clinical trails on familial hyperlipidemia patients also suggested that dietary n-3 
fatty acids might not benefit the liprotein profile (Failor et al., 1988;Hsu et al., 2000). 
The variation of the hepatic ACAT activity caused by the dietary differences 
therefore led us to expect a corresponding cholesterol ester accumulation in FIB hamster 
liver in a pattern close to the results from the ACAT activity assay. However, results 
from our previous study (de Silva et al., 2004) showed that the levels of cholesterol ester, 
free cholesterol, and total cholesterol were not reflective of the results of the ACAT 
assay. The in vivo ACAT activity is dependent on the availability of free cholesterol in 
cells, but the ACAT activity assay was performed in vitro with excess exogenous 
substrates provided in the form of a cholesterol-lipid emulsion. Thus the activity may not 
represent the ACAT activity that would be present in vivo with only the microsomal 
membrane cholesterol as the substrate. Using endogenous cholesterol as substrate in 
additional of radio labeled cholesterol may be an alternative approach to estimate the real 
activity. 
According to the hypothesis, ACAT activity is in part associated with VLDL 
secretion (Rudel et al., 2001). It is possible that the elevation of ACAT activity by the 
high fat diets with cholesterol may subsequently increase the incorporation of the 
cholesterol ester into VLDL particles, which shifts cholesterol ester from the liver to the 
circulation. Although the results from the previous study showed a greater increase in the 
level ofVLDL-cholesterol esters, the VLDL-CE from other diet groups didn't show a 
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pattern associated with ACAT activity. Therefore whether the ACA T activity is 
regulated by the dietary effect is still unclear. 
In brief, we suggest that CYP7 and HMG-CoA reductase, and the corresponding 
transcription factor, SREBP-2, were not regulated by the variation of dietary 
polyunsaturated fats and cholesterol in FIB hamster. These facts surprised us due to the 
extensive literature that suggests these proteins are all regulated by dietary cholesterol 
and fats. These findings led us to examine whether the mechanisms that normally 
regulate SREBP, HMG-CoA Reductase and CYP7 were present and functional in the 
FIB hamster. In particular we focused on the effects of the lipid composition of the 
microsomal fractions from the FlB hamsters on these activities. 
4.3 Dietary effects on Endoplasmic Reticulum Membrane Lipids 
We observed that the levels of cholesterol in FlB hamster liver microsomes were 
affected by the amount and the type of fat in the diet. The high fat and fish oil diets 
appeared to facilitate more cholesterol incorporation into the microsomes. Surprisingly, 
the dietary cholesterol level showed only a minor impact on the microsomal cholesterol 
content when hamsters were fed fish oil and when the animals were fed different amounts 
of the MIX diet there was no effect on the microsomal cholesterol. We also found a 
positive interaction of dietary cholesterol and amount of dietary fat, with an increase in 
the microsomal cholesterol level when the animals were fed high fat diets with 
cholesterol. 
The microsomes were rich in n-3 or n-6 fatty acids when the hamster was fed a fish 
oil or MIX diet, respectively. In addition, the diets had no effect on the levels of 
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microsomal monounsaturated fatty acids. However, when compared to the animals fed 
chow diet, the MUF As were higher and PUF As were lower in hamsters fed experimented 
diet. This indicated that under the influence of the diet, a portion of PUF As were 
substituted by MUF As. Moreover, the content of the major phospholipids (PE, PS, PC, 
SPH) were unaffected by the dietary variations. Thus the changes in the PUF A content 
of the microsomal membranes were limited to substitution of n-6 PUF A with n-3 PUF A. 
4.4 Regression Analysis Between Microsomal Lipids and Enzyme Activity 
The absence of a strong relationship between the dietary variations and the activities 
of microsome associated enzymes, other than ACAT, led us to perform a series of 
regression analyses between the microsomal cholesterol, n-3, n-6 fatty acids and the 
enzyme activities. We found the following: 
1. A positive correlation between the ACAT activity and the content of microsomal 
cholesterol, and n-3 fatty acids respectively. 
2. A positive correlation between the HMG-CoA reductase activity and the content of 
microsomal n-3 fatty acids. 
3. A positive correlation between the content of microsomal cholesterol and n-3 fatty 
acids. 
These results suggested that the activities of microsome associated enzymes, HMG-
CoA reductase and ACA T directly depend on the changes of the microsomal 
environment in FlB hamster liver, especially the interactions between the cholesterol and 
n-3 fatty acids. However the specific mechanisms behind this were not clear. 
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4.4.1 Effects of Membrane Fluidity 
An in vitro study suggested that unsaturated fatty acids are the preferred fatty acid 
substrate for ACAT (Rumsey et al., 1995). In vivo studies in animals have shown that, 
compared with saturated fat diets, unsaturated fats increase the hepatic ACAT activity, 
probably by mediating changes in the microsomal fatty acid content and possibly the 
physical properties of the membrane environment where ACAT resides (Johnson eta!., 
1983;Mathur et al., 1983;Spector et al., 1980). A study in rats showed that soybean 
lecithin supplementation decreased the liver microsomal cholesterol content, and 
increased the membrane fluidity. This resulted in a profound reduction of ACAT 
activity, a minor reduction on HMG-CoA reductase, and no significant effect on CYP7. 
Their results were closely relevant to ours and may further support the hypothesis that the 
activities of microsomal enzymes may be dependent on the membrane fluidity in the 
endoplasmic reticulum. 
There was an absence of any correlation between the levels of cholesterol in the 
hamster liver microsomal fraction and the levels of either the precursor or mature forms 
ofSREBP, the HMG CoA Reductase activity and the Cyp7 activity. However, it should 
be noted that the membranes of the F 1 B hamsters fed either the fish oil diet or the mix 
diet contained 30-45% of polyunsaturated fatty acids. There is a growing body of 
evidence showing that high levels of these polyunsaturated fatty acids in membranes can 
significantly alter the "fluidity" or micro viscosity of membranes with concomitant effects 
on the activity of integral membrane proteins (Hashimoto et al., 1999;Lutz et al., 
1999;Petrache et al., 2001;Wassall et al., 2004). The activity ofHMG CoA Reductase in 
human fibroblast microsomes was shown to be attenuated by increases in order 
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(decreases in fluidity) of the microsomal membranes when the membrane order was 
altered either by changes in free cholesterol content of the membrane or by enrichment of 
the membranes with phospholipids containing saturated fatty acids (Davis and 
Poznansky, 1987). In this study we observed a positive correlation between HMG Co A 
Reductase and the content ofn-3 PUFA in the microsomal membranes. It is possible that 
the ordering effect of cholesterol in the liver microsomes is being offset by the inclusion 
of polyunsaturated fatty acids, especially the high unsaturated n-3 PUFA from fish oil. If 
so, it is interesting that the n-3 PUF A are more effective than the n-6 PUF A as the n-3 
PUF A contain more double bonds that the n-6 PUF A. 
This being said, the fluidity effect would only be expected to impact the post-
translational regulation ofHMG CoA Reductase. It would be unlikely to account for the 
fact that the proteolytic cleavage of the SREBP precursor to the mature form is not 
affected by the different diets. The processing of SREBP is initiated by the 
conformational change of SCAP/SREBP complex when the cholesterol is low in the 
membrane and one would expect a correlation between microsomal cholesterol and the 
level of the mature form of SREBP. However, the levels of mature SREBP did not 
change in the hamster livers. The absence of any effects on SREBP processing might be 
accounted for by differential localization of the protein in the microsomal membrane. 
4.4.2 Membrane Domains 
Wassail et al. have proposed that inclusion of polyunsaturated fatty acids in 
membranes can result in substantial changes in the distribution of both the lipid and 
protein components of the membranes giving rise to cholesterol-rich raft domains and the 
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migration of proteins into cholesterol-poor bulk lipid (non-raft) (Wassail eta!., 2004) as 
illustrated in figure 4.I. This arises from a minimal interaction between cholesterol and 
phospholipids containing polyunsaturated fatty acids, and this is especially true for DHA, 
one ofthe two major n-3 PUF A in fish oil. It is therefore possible that the microsomes 
from the FIB hamsters fed the different diets contain cholesterol-rich domains from 
which much of the SREBP was excluded. The low cholesterol levels in the remaining 
bulk domains would then be insufficient to promote processing of the SREBP precursor 
into the mature form and it's subsequent translocation to the nucleus. This might account 
for the absence of any significant correlation between microsomal cholesterol levels and 
the levels of mature SREBP and concomitant enzyme activities. 
4.5 Summary 
Another student in our lab had discovered that the effects of the amount of dietary fat, 
the types of dietary fat and the amount of dietary cholesterol on the lipoprotein profiles of 
the hypercholesterolemic FIB hamster were different from those reported in other 
species. The original objective of this work was to investigate the effects of these 
changes in dietary lipids in the diet of FIB hamsters on key enzymes involved in 
cholesterol homeostasis. 
The impact ofthe different diets on microsomal enzymes is summarized in table 4.I. 
In our study, we observed that these microsomal enzymes are not especially responsive to 
the type of dietary polyunsaturated fat and cholesterol in the liver of FIB hamster. This 
raised questions about the functionality of the regulatory mechanisms that have been 
shown to account for the effects of dietary fat on cholesterol metabolism in the 
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Figure 4.1 Cartoon depiction of the effect of DHA-containing phospholipids on SM-
/cholesterol-rich raft domains in the outer leaflet of the plasma membrane. 
Wassall et al. proposed a cartoon illustration on how DHA may influence lipid raft size 
and stability. The incorporation of a DHA-containing phospholipid drives cholesterol into 
SM-/cholesterol-rich rafts while DHA accumulates in DHA-rich/cholesterol-poor 
domains, where the proteins reside, within the bulk lipid of the membrane. Steric 
incompatibility between sterol and PUF A is presumed to be responsible (Wassall et al. 
2004). 
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Table 4.1 Summary of the Results 
Source of Microsomal Lopids 
Variation 
Dietary effects Cholesterol n-3 FA 
High fat (A) + 
Fish oil diet (B) + + 
Cholesterol (C) 
AXB 
AXC + 
BXC 
Microsomal 
lipids 
Cholesterol + 
n-3 fatty acid 
+ mdtcates a positive interaction 
- indicates a negative interaction 
Blank cell indicates no interaction 
Hepatic Enzyme Activities 
ACAT CYP7 LDL-R HMG-R SREBP-2 
- -
-
+ 
-
+ 
+ 
+ 
+ + 
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DSNI hamster and in other species. However, the numbers of animal in each diet group 
that were used in the "pilot" study was small and, in many of our analysis of enzyme 
activity or mRNA levels, n was only 2-3. Thus, the high variability may have precluded 
detection of significant effects of the changes in dietary fat and cholesterol. 
Although we did not see major associations between diet and the activity ofHMG-
CoA reductase, CYP7, and SREBP-2 maturation was also not affected by diet, we were 
able to explore the relationships between the lipid content of the microaomal fractions 
and cholesterol regulations. We did regression analysis of our data and observed positive 
interactions between the microsomal n-3 fatty acids and cholesterol content in the 
microsomal membranes and the activities ofHMG-CoA reductase and ACAT. We 
suggest that the activity of the enzymes may affected by the changes in the physical 
properties of the membrane induced by changes in dietary fat. There is also a possibility 
that the increased levels of phospholipids containing n-3 PUF A in the endoplasmic 
reticulum membrane may have led to changes in the lateral distribution of membrane 
lipids that result in the formation of cholesterol-rich domains (rafts) and cholesterol-poor 
domains. The key enzymes in cholesterol metabolism would likely be partitioned into 
the cholesterol-poor domains and thus be unresponsive to cholesterol content in the 
membranes. 
4.6 Future Study 
In order to find out whether the existence of microdomains plays a role in the 
regulation of the enzyme activity, we could determine if the two domains, the SM-
/cholesterol-rich rafts as well as PUF A-rich/cholesterol-poor microdomains, exist in the 
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microsome using various techniques including Nuclear Magnetic Resonance 
Spectroscopy (NMR) or Atomic Force Microscopy (AFM). Also ifthere is evidence that 
these domains exist, the cholesterol-rich lipid rafts could be isolated and the partition of 
the enzymes and SREBP between the rafts and the bulk lipid domains could be 
examined. 
It is also possible to account for the unusual effects of dietary lipids on the plasma 
lipoprotein levels in the FIB hamster was modulated by the assembly and secretion of 
VLDL by the liver. There is some suggestion that the type of fatty acids in the diet may 
affect the activity of the microsomal triglyceride transfer protein (MTTP). It would by 
interesting to determine if MTTP activity is regulated by the diet or the microsomal 
environment in the FIB hamster liver to determine if this might account for the levels of 
hepatic cholesterol ester and plasma VLDL-cholesterol ester. 
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